Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis with meta-analysis | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research article Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis with meta-analysis Ke Chen, Yu Pan, Yi-ping Mou, Chao-jie Huang, Jia-fei Yan, Ren-chao Zhang, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-20225/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Total laparoscopic pancreaticoduodenectomy (TLPD) have been used in the treatment of benign and low-grade diseases on the pancreatic head. It is necessary to expand the current knowledge on the feasibility and safety of TLPD for PDAC treatment. We aimed to assess the surgical and oncological outcomes of TLPD for patients with PDAC by comparing them with open pancreaticoduodenectomy (OPD). Methods Data regarding patients who underwent pancreaticoduodenectomy for PDAC treatment from January 2013 to January 2019 in our hospital were obtained. Baseline characteristics, intraoperative effects, postoperative recoveries, and survival outcomes were compared. To overcome selection bias, we performed a 1:1 match using propensity score matching (PSM) between TLPD and OPD. We also conducted a systematic review and meta-analysis. Results The original cohort included 276 patients (TLPD; 98 patients, OPD; 178 patients). After PSM, there were 89 patients in each group and the patient demographics were well matched. Of the 98 patients who underwent TLPD, 8 (8.2%) required conversions to laparotomies. Compared to OPD, TLPD could be performed with longer operative times, had less blood loss, and had lower overall morbidities. Regarding oncological and survival outcomes, there were no significant differences in tumor size, R0 resection rates and tumor stages between groups. However, TLPD had an advantage over OPD in terms of retrieved lymph nodes (21.9 ± 6.6 vs. 18.9 ± 5.4, p < 0.01). There were no statistically significant differences between the groups in recurrence patterns, and the 3-year recurrence-free and overall survival rates were comparable between the two groups. Meta-analysis further confirmed that the TLPD were associated with longer operative times, less blood loss, shorter hospitalizations, lower morbidities, and a greater number of retrieved lymph nodes. Conclusions TLPD are feasible and oncologically safe procedures for PDAC treatments. Postoperative outcomes and long-term survival after TLPD are superior, or not inferior, to OPD, and could be a promising alternative to open surgery for PDAC treatments. Our findings should be further evaluated by multicenter or randomized controlled trials. Cancer Biology Oncology Laparoscopy Pancreaticoduodenectomy Adenocarcinoma Morbidity Survival Figures Figure 1 Figure 2 Figure 3 Background Pancreatic duct adenocarcinoma (PDAC) is currently the fourth leading cause of cancer-related deaths in developed countries and may rank second by the year 2030 [ 1 , 2 ]. Surgical resection is considered the only method to radically cure this type of cancer [ 3 ]. The surgical extent depends on the tumor location: left-sided PDAC should be treated by subtotal or distal pancreatectomy (DP), and PDAC on the pancreatic head are amendable to pancreaticoduodenectomy (PD). Minimally invasive surgery (MIS), characterized by laparoscopic interventions, have become the standard of care for many surgical procedures across different specialties. The selection of MIS is the professional objective of surgeons and the most acceptable treatment for patients [ 4 ]. However, total laparoscopic PD (TLPD) for PDAC is still in its infancy due to the complexity of the operation and the steep learning curve required for its introduction [ 5 , 6 ]. The Miami International Evidence-based Guidelines suggested that TLPD should be exclusive to experienced surgeons in high-volume centers [ 7 ]. TLPD concerns included the safety, since it is arguably the most complex pancreatic operation, and of oncologic efficacy when performed on patients with PDAC [ 8 ]. Therefore, the role of TLPD in the setting of PDAC is less established and quality data are limited [ 9 ]. In this study, we evaluated the feasibility and safety of TLPD by comparing their short- and long-term clinical outcomes with those of open PD (OPD) through a propensity score-matched analysis to minimize selection bias based on our more than 15 years of experience performing laparoscopic pancreatic surgeries [ 10 ]. In addition, a rapid systematic review with a meta-analysis was conducted to further determine whether TLPD are an acceptable alternative to open surgery for PDAC treatment. Methods Study design and definitions This study was approved by the Ethics Committee of Zhejiang University. Written consent was obtained from every patient prior to surgery. Patients diagnosed with PDAC from January 2013 to January 2019 were identified from our prospectively maintained pancreatic database. The diagnosis of PDAC was based primarily on preoperative imaging, specifically abdominal computed tomography or magnetic resonance imaging. When we initially conducted PD laparoscopically, an epigastric auxiliary incision was sometimes made to facilitate the reconstruction and help us to accumulate experience, which was referred to as a laparoscopic assisted PD (LAPD). TLPDs are characterized by intracorporeal anastomoses without an auxiliary incisions. Cases of LAPD were excluded from this study since TLPD preserve the integrity of the abdominal wall which would create a minimally-invasive advantage for TLPD over LAPD. We routinely conducted multi-disciplinary team treatment models for every major abdominal surgery during which the decision to perform either laparoscopic or open approaches would be discussed followed by a presentation to patients and their families to make a final decision. To minimize selection biases, a 1:1 propensity score matching (PSM) was performed using a logistic regression model and included the following covariates: age, sex, ASA grade, tumor size, and combined resection. Data on patient demographics, clinical presentation, surgical outcomes, tumor characteristics, lymph node status, resection margins, and long-term oncologic outcomes were compared. Postoperative pancreatic fistulas (POPF) were defined and classified according to the 2016 updated International Study Group on Pancreatic Surgery definitions, in which Grade B and C were considered “clinically relevant (CR-POPF)” [ 11 ]. Complications were recorded using the Clavien–Dindo classification system [ 12 ]. Oncologic outcomes were analyzed for all patients, including tumor size (maximum dimensions; cm), total number of lymph nodes (LNs), and margin status. The LN ratio was defined as the number of ([the number of affected LNs/total number of LNs] × 100%). Resection margins were considered negative (R0) when no tumor was evident along the transection surface [ 13 ]. Tumor recurrence was graded as locoregional, extrapancreatic, and multiple. Locoregional recurrences included tumors in adjacent organs, pancreatic remnants, or locoregional LNs. Extrapancreatic recurrences included peritoneal, distant lymphatic or hematogenous metastases. Radiologic evidence of intra-abdominal soft tissue around the operative site and/or distant metastases was defined as tumor recurrence. Recurrence-free survival (RFS) was defined as the time between surgery and diagnosis of recurrence or censoring. Overall survival (OS) was defined as the time between the date of surgery and the date of death from any cause or censoring. Operative Procedure Details of the various operative procedures were previously described [ 10 , 14 ]. Five ports were inserted for the surgeon and the assistant. The surgical extension and protocol was the same as in open surgeries. The lymphadenectomy included the following LN stations: 5 (suprapyloric), 6 (infrapyloric), 8a (common hepatic artery), 12b-c (along the bile duct and cystic duct), 13a-b (along the head of the pancreas), 14a-b (along the right lateral side of superior mesenteric artery), and 17a-b (along the anterior face of the head of the pancreas). Retroperitoneal soft-tissue was completely removed. The intracorporeal Child’s approach was used for the reconstruction along the same principles of in pancreaticojejunostomy (PJ). An end-to-side PJ was conducted as long as a maximum diameter of 2 mm was attained at the pancreatic duct, in spite of the difficulty in identification, while the duct-to-mucosa PJ could be utilized in cases where the pancreatic ducts were over a diameter of 2 mm. All specimens and their margins were routinely sent for intra-operative frozen section examinations. Meta-analysis We searched PubMed, EMBASE, and the Cochrane Library for literature comparing TLPD vs. OPD outcomes in the treatment of PDAC up to December 2019 and broadened the search range by browsing the references of retrieved articles. The following search terms were used: “minimally invasive,” “laparoscopy,” “Whipple,” “pancreaticoduodenectomy,” “pancreatic ductal adenocarcinoma,” and “pancreatic cancer.” The language of the articles was limited to English. Review articles, overlap authors or centers, and articles without adequate statistical data were excluded. All searched articles were reviewed by three authors (K.C., Y.P., and C.J.H), and disagreement was resolved via discussion. The Newcastle–Ottawa Quality Assessment Scale (NOS) was utilized to evaluate the quality of the included studies. Statistical analysis We used SPSS version 23.0 (IBM Corp., Armonk, NY) to perform all statistical analysis. Analysis was performed in the intention to treat population, that is, all patients who received the allocated intervention. Continuous variables are expressed as mean and standard deviation (SD) when the distribution was considered normal, and otherwise using the median, and range. Categorical variables are expressed as absolute numbers and percentages. The Student t test or the Mann–Whitney U test was used for the comparison of continuous variables and the chi-square Chi-square test or the Fisher exact test for categorical variables, depending on the conditions of application. Survival rates and comparisons were estimated by the Kaplan–Meier survival curves and the log-rank test. All reported p values are 2-sided. Values of p < 0.05 were considered to indicate statistically significant differences. For the meta-analysis, Review Manager ver. 5.1 (Nordic Cochrane Center, Copenhagen, Denmark) was used. The effect size was calculated using odds ratio (OR) for dichotomous variables and weighted mean difference (WMD) with 95% confidence interval (CI) for continuous data. To account for clinical heterogeneity, which refers to diversity in a sense that is relevant for clinical situations, we used the random effects model based on DerSimonian and Laird’ s method. p < 0.05 was considered statistically significant. Results Patient selection and clinicopathological characteristics During the study period, 276 patients (TLPD: 98 and OPD: 178) meeting the inclusion and exclusion criteria were selected. After PSM, 89 patients in the TLPD group and 89 patients in the OPD group were included in the final analysis. A flow chart of patient selection is shown in Fig. 1 . Baseline characteristics of patients in both groups are shown in Table 1 . There were no statistically significant baseline characteristic differences between the two groups. PSM enabled better comparability between the two groups. Table 1 Demographics, clinical characteristics before and after matching of TLPD vs. OPD. Variable All patients Propensity-matched patients TLPD (n = 98) OPD (n = 178) p value TLPD (n = 89) OPD (n = 89) p value Age (years) a 63.2 ± 9.3 62.5 ± 9.5 0.54 62.7 ± 7.6 62.4 ± 8.2 0.80 Gender (Male: Female) 63:35 111:67 0.75 58:31 58:31 1.00 BMI (kg/m 2 ) a 22.1 ± 2.6 22.2 ± 3.1 0.88 22.1 ± 2.5 22.4 ± 3.0 0.44 ASA classification (I:II:III) 42:49:7 80:92:6 0.40 41:46:2 38:49:2 0.87 Presence of comorbidity (Yes:No) 44:54 81/97 0.92 40:49 42:47 0.76 Hypertension 22 60 19 29 Diabetes mellitus 16 27 14 14 Cardiovascular 7 5 3 3 Pulmonary 5 6 5 2 Hepatic 3 4 3 0 Others 3 6 3 2 Neoadjuvant chemotherapy (%) 4 (4.1%) 13 (7.3%) 0.29 3 (3.4%) 7 (7.9%) 0.19 a: values were showed as mean (standard deviation) and tested by Student’s t test; b: values were showed median (range) and tested by Mann-Whitney U test. BMI body mass index, ASA American Society of Anesthesiologists. Surgical Data And Postoperative Outcomes Surgical data and postoperative outcomes are summarized in Table 2 . For the 98 TLPD cases, conversion to open surgery was necessary in 8 (8.2%) because of a severe adhesion caused by historical abdominal surgery (n = 1), intraoperative uncontrollable bleeding from the branches of major vessels (superior mesenteric artery, n = 2; gastroduodenal artery, n = 1; portal vein, n = 1), suspicious vascular invasion to achieve safe margins (n = 2); and acidosis due to a long lasting pneumoperitoneum (n = 1). Before PSM, the OPD group had a higher proportion of combined resections (6.1% vs. 11.2%, p = 0.16), which were eliminated by PSM (5.6% vs. 5.6%, p = 1.00). TLPD showed longer operative times than OPD before PSM (425.5 ± 75.0 vs. 382.6 ± 85.4 min, p < 0.01), and the difference was even more obvious after PSM (426.1 ± 75.3 vs. 370.5 ± 85.3 min, p < 0.01). TLPD showed less blood loss (before PSM, 280 [120–900] vs. 400 [200–1500] mL, p < 0.01; after PSM, 260 [120–900] vs. 400 [200–1200) mL, p < 0.01], and fewer blood transfusions (before PSM, 16.3% vs. 30.3%, p = 0.01; after PSM, 15.7% vs. 28.1%, p = 0.04) before and after PSM. The median hospital stay (after PSM, 13 [8–69] vs. 19 [11–52] days, p < 0.01) was longer in the OPD group than in the LPD group. Two in-hospital mortalities were noted: each group had one severe postoperative pancreatic fistula (POPF), and the patients died of multisystem organ failure secondary to sepsis. After PSM, 31 patients in the OPD group and 17 in the TLPD group experienced postoperative complications (after PSM, 20.2% vs. 33.7%, p = 0.02). For specific complications, delayed gastric emptying (DGE) (5.6% vs. 11.2%, p = 0.18) and pulmonary complications (1.1% vs. 5.6%, p = 0.11) were more frequent in the OPD group; however, the difference between the groups did not attain statistical significance. Morbidity in the OPD group was serious according to the Clavien–Dindo classification, but the difference also did not attain statistical significance ( p = 0.12). Table 2 Surgical data and postoperative outcomes before and after matching of TLPD vs. OPD. Variable All patients Propensity-matched patients TLPD (n = 98) OPD (n = 178) p value TLPD (n = 89) OPD(n = 89) p value Operative time (min) a 425.5 ± 75.0 382.6 ± 85.4 < 0.01 426.1 ± 75.3 370.5 ± 85.3 < 0.01 Estimated blood loss (mL) b 280 (120–900) 400 (200–1500) < 0.01 260 (120–900) 400 (200–1200) < 0.01 RBC transfusion (%) 16 (16.3%) 54 (30.3) 0.01 14 (15.7%) 25 (28.1%) 0.04 Combined resection 6 (6.1%) 20 (11.2%) 0.16 5 (5.6%) 5 (5.6%) 1.00 Postoperative hospital stay (days) b 13.5 (8–69) 19 (9–72) < 0.01 13 (8–69) 19 (11–52) < 0.01 Overall morbidity (n, %) 20 (20.4%) 62 (34.8%) 0.01 17 (19.1%) 31 (33.7%) 0.02 CR-POPF 11 (11.2%) 29 (16.3%) 0.24 11 (12.4%) 15 (16.8%) 0.40 Delayed gastric emptying 5 (5.1%) 16 (9.0%) 0.24 5 (5.6%) 10 (11.2%) 0.18 Hemorrhage 4 (4.1%) 17 (9.6%) 0.10 4 (4.5%) 8 (9.0%) 0.23 Bile leak 2 (2.0%) 6 (3.4%) 0.41 2 (2.2%) 3 (3.4%) 0.50 Wound infection 0 (0%) 3 (1.7%) 0.27 0 (0%) 1 (1.1%) 0.50 Lymphorrhea 0 (0%) 2 (1.1%) 0.42 0 (0%) 2 (2.2%) 0.25 Pulmonary complications 2 (2.0%) 13 (7.3%) 0.07 1 (1.1%) 5 (5.6%) 0.11 Reoperation (%) 5 (5.1%) 13 (7.3%) 0.48 4 (4.5%) 6 (6.7%) 0.52 Clavien-Dindo classification 0.05 0.12 I-II 9 28 7 15 III-IV 10 33 9 15 V (90-day mortality) 1 1 1 1 a: values were showed mean (standard deviation) and tested by Student’s t test; b: values were showed median (range) and tested by Mann-Whitney U test. RBC: red blood cell. Pathology Examination And Oncological Outcomes Pathology examination outcomes are listed in Table 3 . Before PSM, the TLPD group had smaller tumor sizes. After PSM, pathological examination revealed that tumor size, pT-stage, and pN-stage were well matched between the two groups. The TLPD group was associated with a significantly higher number of harvested LNs than the OPD group (21.9 ± 6.6 vs. 18.9 ± 5.4, p < 0.01), whereas the radical R0 resection rates, positive LNs, and LN ratios were comparable between the two groups. Table 3 Pathology examination before and after matching of TLPD vs. OPD. Variable All patients Propensity-matched patients TLPD (n = 98) OPD (n = 178) p value TLPD (n = 89) OPD (n = 89) p value Tumor size a 3.0 ± 0.9 3.5 ± 1.2 < 0.01 3.0 ± 0.9 3.0 ± 1.0 0.74 Differentiation 0.88 0.52 Well 31 62 29 35 Moderate 41 72 35 35 Poor 26 44 25 19 R0 resection (%) 88 (89.8%) 148 (83.1%) 0.13 82 (92.1%) 78 (87.6%) 0.32 Retrieved lymph node a 21.8 ± 6.5 18.9 ± 5.7 < 0.01 21.9 ± 6.6 18.9 ± 5.4 < 0.01 Positive lymph node b 1 (0–14) 1 (0–11) 0.98 1 (0–14) 0 (0–10) 0.84 Lymph node ratio b 3.3 (0–50) 3.5 (0–50) 0.48 3.1 (0–50) 0 (0–50) 0.71 Pathologic T stage 0.24 0.89 T1 10 24 12 15 T2 72 113 64 62 T3 16 41 13 12 Pathologic N stage 0.22 0.48 N0 45 87 42 45 N1 45 66 40 34 N2 8 25 7 11 a: values were showed as mean (standard deviation) and tested by Student’s t test; b: values were showed median (range) and tested by Mann-Whitney U test. The oncological outcomes are summarized in Table 4 . The median follow-up times were 25 (10–58) months and 23 (10–83) months in the TLPD and OPD groups, respectively. Before PSM, recurrence occurred in 70 patients (71.4%) in the TLPD group including 19 (27.1%) locoregional, 33 (47.1%) extrapancreatic, and 18 (25.7%) combined locoregional/extrapancreatic recurrences, and 138 patients (77.5%) in the OPD group including 31 (17.4%) locoregional, 57 (32.0%) extrapancreatic, and 50 (28.1%) multiple recurrences, without statistically significant difference between the two groups ( p = 0.26). There were also no statistically significant differences in recurrence patterns ( p = 0.31) between the two groups. However, statistically improved recurrence-free and overall survival outcomes (before PSM, median survival, 95% CI: 26 [20.4–31.6] vs. 19 [16.7–21.3] months, p = 0.02) were identified in the TLPD group as shown in Table 4 , and Fig. 2 A and Fig. 2 B. After PSM, there was no difference in any of the values, indicating the procedures have equivalent oncologic outcomes. Although the TLPD group showed a slightly longer median survival time than the OPD group (25 [19.4–30.6] vs. 21 [17.4–24.6] months), there was no statistically significant difference in regard to survival outcomes between the two groups ( p = 0.29) as shown in Table 4 and Fig. 2 C Fig. 2 D. Table 4 Oncological outcomes before and after matching of TLPD vs. OPD. Variable All patients Propensity-matched patients TLPD (n = 98) OPD (n = 178) p value TLPD (n = 89) OPD (n = 89) p value Recurrence 70 (71.4%) 138 (77.5%) 0.26 62 (69.7%) 66 (74.2%) 0.51 Initial sites of recurrence 0.31 0.61 Locoregional 19 (27.1%) 31 (17.4%) 15 (24.2%) 16 (24.2%) Extrapancreatic 33 (47.1%) 57 (32.0%) 31 (50.0%) 27 (40.9%) Multiple 18 (25.7%) 50 (28.1%) 16 (25.8%) 23 (34.8%) RFS 0.04 0.29 1-year 62.5% 49.1% 62.1% 54.3% 2-year 38.7% 28.2% 39.5% 31.5% 3-year 20.6% 19.2% 21.8% 22.7% OS 0.02 0.29 1-year 88.5% 68.9% 87.4% 71.6% 2-year 53.9% 37.8% 52.4% 44.0% 3-year 31.8% 22.1% 33.3% 27.3% Median survival (95% CI) 26 (20.4–31.6) 19 (16.7–21.3) 25(19.4–30.6) 21(17.4–24.6) RFS recurrence-free survival, OS overall survival, CI confidence interval. Outcomes Of The Systematic Review And Meta-analysis The initial search strategy retrieved 968 English publications. Of these, 86 articles were selected based on their titles and abstracts, and a full examination of the texts was performed. Seventy-eight papers were excluded since they contained pancreatic head and periampullary malignancies in addition to PDAC. A further 4 studies were excluded due to inadequate statistical data [ 15 – 18 ]. A study evaluating LAPD instead of TLPD for PDAC treatment was also excluded [ 19 ]. One study reported the data from the National Cancer Database (NCDB) [ 20 ], which compiled cancer registry data in the U.S. and Puerto Rico. Due to the risk of overlapping data with other included studies, this study was also excluded. Finally, only two articles remained [ 21 , 22 ], each receiving 8 Newcastle–Ottawa (NOS) points. Both articles represent the American experience. A flow chart of the search strategies is illustrated in Fig. 1 . Including the present data (after PSM), there were 751 participants in three studies (255 patients in the TLPD group and 496 patients in the OPD group). The conversion rates of the two included studies were 6.5% (7/108) [ 21 ] and 24.1% (14/58) [ 22 ], respectively. Although TLPD seemed to have longer durations, the meta-analysis of operative times showed no significant differences between the two groups (WMD = 62.78 min, 95% CI: -17.86 to 143.42, p = 0.13; Fig. 3 A). However, the intraoperative blood loss was lower in TLPD than in OPD (WMD = -256.94 mL, 95% CI: -461.87 to -52.01, p = 0.01; Fig. 3 B), as were the transfusion rates (OR = 0.45, 95% CI: 0.32 to 0.66, p < 0.01; Fig. 3 C). The pooled data further showed shorter lengths of hospital stays with respect to TLPD (WMD = -4.59 days, 95% CI: -6.70 to -2.48, p < 0.01; Fig. 3 D). In addition, the pooled analysis indicated that the rate of overall morbidity was significantly lower in the TLPD group (OR = 0.51, 95% CI: 0.36 to 0.70, p < 0.01; Fig. 3 E). Separate analyses were performed by dividing the overall morbidity into major and minor complications according to the Clavien–Dindo classification, in which major complications were graded from III to V and minor ones were graded I and II [ 23 ]. We found that both major (OR = 0.55, 95% CI: 0.35 to 0.88, p = 0.01; Fig. 3 F) and minor complications (OR = 0.66, 95% CI: 0.46 to 0.95, p < 0.01; Fig. 3 G) were significantly lower in the TLPD group. However, our meta-analysis showed there was no statistically significant difference in mortality (OR = 0.65, 95% CI: 0.21 to 2.06, p = 0.46; Fig. 3 H) between the two groups. For oncologic outcomes, results showed comparable tumor sizes (WMD = -0.16 cm, 95% CI: -0.53 to 0.21, p = 0.40; Fig. 3 I). The pooled data of retrieved LNs showed that the number of LNs from TLPD was greater than that of the open group (WMD = 4.19, 95% CI: 0.64 to 7.75, p = 0.02; Fig. 3 J). Pooling results indicated a comparable R0 rate between the groups (OR = 1.23, 95% CI: 0.82 to 1.86, p = 0.32; Fig. 3 K). Both studies reported no significant difference in the survival rates between the two groups during their follow-up times. However, quantitative analyses of long-term survival outcomes were not performed due to limited data. Discussion Pancreatectomy with lymphadenectomy remains the first-line treatment option for early- and intermediate-stage PDAC. Although laparoscopic DP have become important options for all indications including PDAC on pancreatic bodies and tails [ 7 , 24 ], approaching PD laparoscopically for diseases on pancreatic heads were less frequent owing to the intricacy of the dissection and the complexity of the pancreatoenteric and biliodigestive anastomoses [ 5 , 8 ]. This study suggested that TLPD for PDAC were technically feasible and safe. TLPD are longer operations for PDAC treatment than OPD but exhibit clear benefits of less blood loss and shorter hospitalization. More importantly, we found TLPD were associated with lower morbidities than open surgery for PDAC treatments. In addition, laparoscopic procedures appear to hold potential advantages in terms of R0 resections and retrieved LNs. The meta-analysis further confirmed our short-term surgical outcomes. Nevertheless, no statistically significant differences were identified between laparoscopic and open procedures for the treatment of PDAC in the long-term oncological outcomes of recurrence patterns and survival. The prolonged operative time in TLPD is an obvious disadvantage. Our initial TLPD for PDAC lasted for nearly 600 minutes [ 14 ]. Currently, this can be completed in approximately 300–350 minutes [ 10 ]. Kendrick et al., in one of the largest single series currently available, described their initial TLPD duration to be 460 min, which improved to 320 min after approximately 50 cases [ 25 ]. Stauffer et al., reported a median operative time of 518 min, which was significantly longer than that in open surgery (140 min) [ 22 ]. The learning curve can be overcome in high volume centers, with average TLPD operative times decreasing to less than 400 min [ 26 ]. However, due to tumor biology and the aggressiveness of the disease process, TLPD for PDAC treatments are not commonly performed making it difficult to overcome the associated learning curve [ 5 ]. Although none of studies identified adverse outcomes, a recent study from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) demonstrated that longer operative times were independently associated with worse perioperative outcomes after pancreatic resections [ 27 ]. Therefore, we believe long duration is a definite disadvantage of TLPD for PDAC treatments. In this ITT analysis, the conversion rates were 8.2% (8/98) for all TLPD cases. We found that the conversions generally were due to hemorrhages that were difficult to control or had suspected vessel involvement, which was similar to other publications of TLPD for PDAC treatment [ 21 , 22 ]. Although there was less overall blood loss, there were still 4 conversions for intraoperative uncontrollable bleeding in this TLPD group. In fact, the multicenter LEOPARD-2 trial was stopped prematurely due to safety concerns of higher mortalities in the LPD group mainly because of intraoperative bleeding [ 28 ]. We believe that part of the reason that PDAC frequently induces substantial pancreatic inflammation in the pancreatic remnant is because it is harder to resect due to pronounced adhesions to the surrounding tissues or infiltrations of the portal vein. Portomesenterical vein involvement is a common clinical finding in PDAC, but is a situation that is frequently difficult to diagnose prior to surgery [ 29 ]. The rate of venous involvement ranges from 26 to 85% in the literature [ 30 – 32 ]. Portomesenteric vein resection is a mean of achieving complete tumor clearance. However, researchers strongly recommend that venous resection during TLPD should only be performed by surgeons with considerable TLPD experience with TLPD and proficiency in open vascular resection [ 33 , 34 ]. Therefore, approaching appropriate cases like no vessel involvement or severe adhesions laparoscopically in the learning curve would reduce conversion helping to shorten operative time and further reduce bleeding [ 28 ]. The most important concern regarding TLPD for PDAC treatments is the patient’s safety. We found less postoperative morbidities in TLPD than in OPD (after PSM, 19.1% vs. 33.7%, p = 0.02). Furthermore, the meta-analysis indicated not only overall less morbidities in TLPD group, but major and minor complications were also less in the TLPD group when dividing overall complications into major and minor ones according to the Clavien–Dindo classification. POPF is a frequent event and the best management for the pancreatic stump is still under debate with our results revealing no significant differences between the two groups. The anastomoses performed during LPD are the main topic of concern. However, there is no consensus on the best method of anastomosis after PD (e.g., pancreaticojejunostomy or pancreaticogastrostomy, duct-to-mucosa or invagination anastomosis, etc.) [ 9 ]. The reported methods in open surgery now can be meticulously performed laparoscopically [ 5 , 35 ]. No appreciable differences were noted between groups for POPFs because the true risk factors of significant POPFs have been recognized as soft pancreatic parenchyma, high-risk disease pathology, and small pancreatic duct size, rather than the anastomosis method [ 36 , 37 ]. We argue that the main contributors of lower morbidity in TPLD were reduced delayed gastric emptying (DGE) (after PSM, 5.6% vs. 11.2%, p = 0.18) and pulmonary complications (after PSM, 1.1% vs. 5.6%, p = 0.11). DGE is not life threatening, but can have significant consequences such as patient discomfort, prolonged hospital stays, increased hospital costs, diminished nutritional status, and delays in initiation of adjuvant therapy [ 38 , 39 ]. According to the literature, the pathogenesis of DGE is multifactorial and given the improved access and visualization of the laparoscopic approach, as well as the meticulous attention to techniques, potential reasons for this advantage include [ 40 , 41 ]: 1) laparoscopic surgery has less influence on the peripheral organs and peritoneum leading to less seroperitoneum helping to alleviate of gastric dysrhythmias, 2) ameliorative pyloric or antral ischemia due to reservation of small vessels, and 3) mitigant pylorospasms secondary to denervation of the stomach and duodenum or jejunum. As one of the most complex abdominal surgeries, PD involves multiple systems and would cause more medical complications than other surgeries. It is well known that major abdominal surgery has a detrimental effect on respiratory function, and this is particularly true in upper abdominal surgeries. In general, open procedures are reported to portend a higher risk of pleural effusions, pulmonary infections, and atelectasis than do minimally invasive ones [ 42 , 43 ]. Oncologic safety and efficacy should be clearly demonstrated prior to a wide application of a new surgical approach. The long-term survival outcomes of MIS for common malignancies have conflicting results [ 44 – 46 ], leading to a constant controversy over MIS for cancer treatments. Oncological surgery requires a radical resection, adequate lymphadenectomy, and meticulous ‘no-touch’ dissection as it may prevent seeding and tumor cell dissemination. R0 resection is frequently referred to as a crucial factor, which is deemed the only hope for cure [ 47 ]. Tactile evaluation of tissue is not possible during laparoscopy and was presumed to lead to inadequate surgical margins. Nevertheless, our study revealed that the R0 resection of TLPD are comparable to those of open surgery. In addition, our data showed the retrieved LNs of TLPD were not inferior to those of OPD, or even superior to OPD for lymphadenectomy (after PSM, 21.9 ± 6.6 vs. 18.9 ± 5.4, p < 0.01). These findings were further confirmed by the rapid meta-analysis. The advantages of high-resolution imaging, multi-dimensional vision, and meticulous manipulation help to facilitate lymphadenectomy. A single-center study conducted by Asbun and Stauffer, reported a comparable long-term survival of 1-, 2-, 3-, 4-, and 5-years for OPDs (68, 40, 24, 17, and 15%) and for TLPDs (67, 43, 43, 38, and 32%), respectively [ 22 ]. Kuesters et al., conducted a series of LAPD, also reported a comparable 5-year survival rate between LAPD (20%) and OPD (14%) for PDAC [ 19 ]. Croome et al., recorded that the progression-free survival was longer in TLPD [ 21 ]. In this analysis, we found patients' survival in the TLPD group was superior to those in the OPD group before PSM (RFS: p = 0.04, OS: p = 0.02). After PSM, in which tumor size and stage were balanced, the 3-year OS and DFS in the TLPD group were still slightly higher than in the OPD group, but the differences failed to reach statistical significance. We believe our results were credible since PSM established the oncologic equivalence of two surgical techniques. We considered there may be other reasons for such results in addition to more LNs examined in the laparoscopic groups. One hypothesis was that improved recovery after laparoscopic surgery helped to instigate multimodality therapies earlier, thus leading to survival benefits [ 21 ]. However, a retrospective analysis of the NCDB found that MIS did not improve use or initiation of adjuvant chemotherapy for patients with PDAC [ 48 ]. Moreover, the survival impact of the initiation time of adjuvant chemotherapy in patients with resected PDAC remains uncertain since studies showed conflicting results [ 49 , 50 ]. In our opinion, neither procedure is technically superior, but efficiency would largely depend on the techniques of the surgeon. Thus, considering the principles of radical resection, a technically similar oncologic resection could be performed regardless of whether the an open or laparoscopic approach was used. Limitations of this study include its retrospective design, small sample size, absence of randomization, and short follow-up period. However, given the fact that TLPD for patients with PDAC are associated with novelty and unpredictable risks, the current study enrolled a relatively large number of cases. To overcome the selection bias arising from a lack of randomization, we performed PSM analyses which was deemed as the most effective method to balance the covariates and thus reduce bias in the retrospective studies. Conclusions The current PSM with meta-analysis demonstrated that TLPD for patients with PDAC was a safe alternative to OPD, as it was associated with less blood loss and a better postoperative recovery in terms of a shorter hospital stay and fewer complications. However, this technique also has the disadvantage of longer operative times. Oncological outcomes of TLPD were not inferior to traditional open procedures. Higher levels of evidence including controlled trials are needed to elucidate clear conclusions. Abbreviations PDAC: pancreatic ductal adenocarcinoma, TLPD: total laparoscopic pancreaticoduodenectomy, LPD: laparoscopic pancreaticoduodenectomy OPD: open pancreaticoduodenectomy, DP: distal pancreatectomy, MIS: minimally invasive surgery, LAPD: laparoscopic assisted pancreaticoduodenectomy, PSM: propensity score matching, ITT: intention-to-treat, ISGPF: International Study Group on Pancreatic Fistula, POPF: postoperative pancreatic fistula, CR-POPF: clinically relevant POPF, RFS: recurrence-free survival, OS: overall survival, PJ: pancreaticojejunostomy, SD: standard deviation, NOS: Newcastle-Ottawa Quality Assessment Scale, OR: odds ratio, WMD: weighted mean difference, CI: confidence interval, NCDB: National Cancer Database, NSQIP: National Surgical Quality Improvement Program, BMI: body mass index, ASA: American Society of Anesthesiologists, RBC: red blood cell. Declarations Ethics approval and consent to participate This study was approved by the Ethics Committee of Zhejiang University. Written consent was obtained from every patient prior to surgery. Consent for publication Not applicable. Availability of data and materials The datasets generated and/or analyzed during the current study are not publicly available due to data privacy according to the license for the current study, but are available from the corresponding author on reasonable request. Competing interests The authors declare that they have no competing interests. Funding This research was supported by Scientific and Technological Project of Zhejiang Province (Grant No. LGF20H030009). The funders had no role in study design, data collection and analysis, interpretation of data and preparation of the manuscript. Authors' contributions CK, PY and HCJ wrote the manuscript; CK, MYP, YJF, ZRC, ZMZ, WGY, WXF, and CQL performed the operations; PY, HCJ and CQL reviewed the medical records and collected data; MYP and CQL proofread and revised the manuscript; all authors read and approved the final manuscript. Acknowledgements No additional investigators were involved in this research project. References Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries . CA Cancer J Clin 2018, 12 (10):21492. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States . Cancer Res 2014, 74 (11):2913-2921. Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Dervenis C, Bassi C et al : Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials . Arch Surg 2008, 143 (1):75-83. Gawande A: Two hundred years of surgery . N Engl J Med 2012, 366 (18):1716-1723. Anderson B, Karmali S: Laparoscopic resection of pancreatic adenocarcinoma: dream or reality? World J Gastroenterol 2014, 20 (39):14255-14262. Edwin B, Sahakyan MA, Abu Hilal M, Besselink MG, Braga M, Fabre JM, Fernandez-Cruz L, Gayet B, Kim SC, Khatkov IE: Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference . Surgical endoscopy 2017, 31 (5):2023-2041. Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D'Angelica MI, Balduzzi A, Bassi C, Bjornsson B et al : The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection . Ann Surg 2020, 271 (1):1-14. de Rooij T, Klompmaker S, Abu Hilal M, Kendrick ML, Busch OR, Besselink MG: Laparoscopic pancreatic surgery for benign and malignant disease . Nat Rev Gastroenterol Hepatol 2016, 13 (4):227-238. Kendrick ML, van Hilst J, Boggi U, de Rooij T, Walsh RM, Zeh HJ, Hughes SJ, Nakamura Y, Vollmer CM, Kooby DA et al : Minimally invasive pancreatoduodenectomy . HPB 2017, 19 (3):215-224. Chen K, Pan Y, Mou YP, Wang GY, Zhang RC, Yan JF, Jin WW, Zhang MZ, Chen QL, Wang XF: Evolution of Laparoscopic Pancreatic Resections for Pancreatic and Periampullary Diseases: Perioperative Outcomes of 605 Patients at a High-Volume Center . J Laparoendosc Adv Surg Tech A 2019, 29 (9):1085-1092. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG et al : The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After . Surgery 2017, 161 (3):584-591. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey . Ann Surg 2004, 240 (2):205-213. Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, Sobin LH: A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status . Cancer 2009, 115 (15):3483-3488. Zhang MZ, Xu XW, Mou YP, Yan JF, Zhu YP, Zhang RC, Zhou YC, Chen K, Jin WW, Matro E et al : Resection of a cholangiocarcinoma via laparoscopic hepatopancreato- duodenectomy: a case report . World J Gastroenterol 2014, 20 (45):17260-17264. Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, Park KM, Lee YJ: Matched Case-Control Analysis Comparing Laparoscopic and Open Pylorus-preserving Pancreaticoduodenectomy in Patients With Periampullary Tumors . Ann Surg 2015, 262 (1):146-155. Dokmak S, Fteriche FS, Aussilhou B, Bensafta Y, Levy P, Ruszniewski P, Belghiti J, Sauvanet A: Laparoscopic pancreaticoduodenectomy should not be routine for resection of periampullary tumors . J Am Coll Surg 2015, 220 (5):831-838. Chen S, Chen JZ, Zhan Q, Deng XX, Shen BY, Peng CH, Li HW: Robot-assisted laparoscopic versus open pancreaticoduodenectomy: a prospective, matched, mid-term follow-up study . Surg Endosc 2015, 29 (12):3698-3711. Boggi U, Napoli N, Costa F, Kauffmann EF, Menonna F, Iacopi S, Vistoli F, Amorese G: Robotic-Assisted Pancreatic Resections . World J Surg 2016, 40 (10):2497-2506. Kuesters S, Chikhladze S, Makowiec F, Sick O, Fichtner-Feigl S, Hopt UT, Wittel UA: Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study . Int J Surg 2018, 55 :162-166. Kantor O, Talamonti MS, Sharpe S, Lutfi W, Winchester DJ, Roggin KK, Bentrem DJ, Prinz RA, Baker MS: Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy . Am J Surg 2017, 213 (3):512-515. Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML: Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg 2014, 260 (4):633-638. Stauffer JA, Coppola A, Villacreses D, Mody K, Johnson E, Li Z, Asbun HJ: Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution . Surg Endosc 2017, 31 (5):2233-2241. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C et al : The Clavien-Dindo classification of surgical complications: five-year experience . Ann Surg 2009, 250 (2):187-196. Plotkin A, Ceppa EP, Zarzaur BL, Kilbane EM, Riall TS, Pitt HA: Reduced morbidity with minimally invasive distal pancreatectomy for pancreatic adenocarcinoma . HPB 2017, 19 (3):279-285. Kendrick ML, Cusati D: Total laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience . Arch Surg 2010, 145 (1):19-23. Chen K, Pan Y, Liu XL, Jiang GY, Wu D, Maher H, Cai XJ: Minimally invasive pancreaticoduodenectomy for periampullary disease: a comprehensive review of literature and meta-analysis of outcomes compared with open surgery . BMC Gastroenterol 2017, 17 (1):017-0691. Maggino L, Liu JB, Ecker BL, Pitt HA, Vollmer CM, Jr.: Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database . Journal of the American College of Surgeons 2018. van Hilst J, de Rooij T, Bosscha K, Brinkman DJ, van Dieren S, Dijkgraaf MG, Gerhards MF, de Hingh IH, Karsten TM, Lips DJ et al : Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial . Lancet Gastroenterol Hepatol 2019, 4 (3):199-207. Teramura K, Noji T, Nakamura T, Asano T, Tanaka K, Nakanishi Y, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S: Preoperative diagnosis of portal vein invasion in pancreatic head cancer: appropriate indications for concomitant portal vein resection . J Hepatobiliary Pancreat Sci 2016, 23 (10):643-649. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M: Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy . Arch Surg 2003, 138 (12):1316-1322. Bachellier P, Nakano H, Oussoultzoglou PD, Weber JC, Boudjema K, Wolf PD, Jaeck D: Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 2001, 182 (2):120-129. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA et al : Pancreaticoduodenectomy with vascular resection: margin status and survival duration . J Gastrointest Surg 2004, 8 (8):935-949. Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML: Pancreaticoduodenectomy with major vascular resection: a comparison of laparoscopic versus open approaches . J Gastrointest Surg 2015, 19 (1):189-194. Kendrick ML, Sclabas GM: Major venous resection during total laparoscopic pancreaticoduodenectomy . HPB 2011, 13 (7):454-458. Kendrick ML, van Hilst J, Boggi U, de Rooij T, Walsh RM, Zeh HJ, Hughes SJ, Nakamura Y, Vollmer CM, Kooby DA et al : Minimally invasive pancreatoduodenectomy . HPB : the official journal of the International Hepato Pancreato Biliary Association 2017, 19 (3):215-224. Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM, Jr.: A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy . Journal of the American College of Surgeons 2013, 216 (1):1-14. Panni RZ, Guerra J, Hawkins WG, Hall BL, Asbun HJ, Sanford DE: National Pancreatic Fistula Rates after Minimally Invasive Pancreaticoduodenectomy: A NSQIP Analysis . Journal of the American College of Surgeons 2019, 21 (19):30151-30156. Akizuki E, Kimura Y, Nobuoka T, Imamura M, Nagayama M, Sonoda T, Hirata K: Reconsideration of postoperative oral intake tolerance after pancreaticoduodenectomy: prospective consecutive analysis of delayed gastric emptying according to the ISGPS definition and the amount of dietary intake . Annals of surgery 2009, 249 (6):986-994. Marsh Rde W, Talamonti MS, Katz MH, Herman JM: Pancreatic cancer and FOLFIRINOX: a new era and new questions . Cancer Med 2015, 4 (6):853-863. Park YC, Kim SW, Jang JY, Ahn YJ, Park YH: Factors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy . J Am Coll Surg 2003, 196 (6):859-865. Jung JP, Zenati MS, Dhir M, Zureikat AH, Zeh HJ, Simmons RL, Hogg ME: Use of Video Review to Investigate Technical Factors That May Be Associated With Delayed Gastric Emptying After Pancreaticoduodenectomy . JAMA Surg 2018, 153 (10):918-927. Fuks D, Cauchy F, Fteriche S, Nomi T, Schwarz L, Dokmak S, Scatton O, Fusco G, Belghiti J, Gayet B et al : Laparoscopy Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection: A Propensity Score Analysis . Annals of surgery 2016, 263 (2):353-361. Sulpice L, Farges O, Goutte N, Bendersky N, Dokmak S, Sauvanet A, Delpero JR: Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study . Ann Surg 2015, 262 (5):868-873. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J: Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial . Jama 2015, 314 (13):1356-1363. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N et al : Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer . N Engl J Med 2018, 379 (20):1895-1904. Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X et al : Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial . Jama 2019, 321 (20):1983-1992. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, Madura JA, Wiebke EA, Lillemoe KD: A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer . Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2006, 10 (10):1338-1345. Nussbaum DP, Adam MA, Youngwirth LM, Ganapathi AM, Roman SA, Tyler DS, Sosa JA, Blazer DG, 3rd: Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma . Ann Surg Oncol 2016, 23 (3):1026-1033. Kim HW, Lee JC, Lee J, Kim JW, Kim J, Hwang JH: Early versus delayed initiation of adjuvant treatment for pancreatic cancer . PLoS One 2017, 12 (3). Mirkin KA, Greenleaf EK, Hollenbeak CS, Wong J: Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer . Cancer 2016, 122 (19):2979-2987. Supplementary Files PRISMAChecklist.doc Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-20225","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research article","associatedPublications":[],"authors":[{"id":463458,"identity":"b935cde6-12df-46a1-8ec2-bdb310f9d62e","order_by":1,"name":"Ke Chen","email":"","orcid":"","institution":"Zhejiang University School of Medicine Sir Run Run Shaw Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Ke","middleName":"","lastName":"Chen","suffix":""},{"id":463459,"identity":"0f48ef14-427f-4c6f-8433-dff8d3d87469","order_by":2,"name":"Yu Pan","email":"","orcid":"","institution":"Zhejiang University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yu","middleName":"","lastName":"Pan","suffix":""},{"id":463460,"identity":"f0657168-345f-4bc1-94fc-3c54f5ddc2af","order_by":3,"name":"Yi-ping Mou","email":"","orcid":"","institution":"Zhejiang Provincial People's Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Yi-ping","middleName":"","lastName":"Mou","suffix":""},{"id":463461,"identity":"b50786c4-a478-4c42-a0b8-33e5f7e387a1","order_by":4,"name":"Chao-jie Huang","email":"","orcid":"","institution":"Zhejiang University","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Chao-jie","middleName":"","lastName":"Huang","suffix":""},{"id":463462,"identity":"2b60aa7a-c403-46d2-b470-b7561cb9b8e1","order_by":5,"name":"Jia-fei Yan","email":"","orcid":"","institution":"Zhejiang University School of Medicine Sir Run Run Shaw Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Jia-fei","middleName":"","lastName":"Yan","suffix":""},{"id":463463,"identity":"234c3fe4-b4c3-4dc5-a394-add336e88a02","order_by":6,"name":"Ren-chao Zhang","email":"","orcid":"","institution":"Zhejiang Provincial People's Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Ren-chao","middleName":"","lastName":"Zhang","suffix":""},{"id":463464,"identity":"47e6909a-0c31-4c73-9763-448bd3511293","order_by":7,"name":"Miao-zun Zhang","email":"","orcid":"","institution":"Ningbo Medical Treatment Centre Li Huili Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Miao-zun","middleName":"","lastName":"Zhang","suffix":""},{"id":463465,"identity":"71685473-3acc-477c-b253-ec17cb4422a7","order_by":8,"name":"Guan-yu Wang","email":"","orcid":"","institution":"Zhejiang University School of Medicine Sir Run Run Shaw Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Guan-yu","middleName":"","lastName":"Wang","suffix":""},{"id":463466,"identity":"237fbbff-0791-4007-9053-decf4f698d87","order_by":9,"name":"Xian-fa Wang","email":"","orcid":"","institution":"Zhejiang University School of Medicine Sir Run Run Shaw Hospital","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Xian-fa","middleName":"","lastName":"Wang","suffix":""},{"id":463467,"identity":"6bae2b82-2656-4031-8824-9fdd611ba6e3","order_by":10,"name":"Qi-long Chen","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA5ElEQVRIiWNgGAWjYBAC9gbGBmYGhgMgFoMBUICxgZAWngOMjc1gLTwHiNbCwAjRIpEAFiBCC/vh9scFNXfkzCWfPyjmYbCR3XCA+dkDvFp4EhubZxx7Zmw5OyHBmIchzXjDATZzA3xa7BmAWngbDiduuJ1wAKgFyDjAwyaB1xb+h2At9RtuHmwAavlPhBYJiC0JBjeYGYBaDhCj5WHjbJ5jhw03nEljMJxjkGw88zCbGQGHpT/4zFNzWN7g+PFnBm8q7GT7jjc/w6sFGbAZgCOTmVj1ILUPSFA8CkbBKBgFIwgAAF9UTDPPJWVnAAAAAElFTkSuQmCC","orcid":"","institution":"Zhejiang University School of Medicine Sir Run Run Shaw Hospital","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Qi-long","middleName":"","lastName":"Chen","suffix":""}],"badges":[],"createdAt":"2020-03-30 17:04:10","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-20225/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-20225/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":845383,"identity":"a997e8d6-786a-4f8c-9882-36575f3a2051","added_by":"auto","created_at":"2020-04-06 17:22:03","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":763347,"visible":true,"origin":"","legend":"Flow chart of patient selection and literature search strategy.","description":"","filename":"Figure01.jpg","url":"https://assets-eu.researchsquare.com/files/rs-20225/v1/Figure01.jpg"},{"id":845384,"identity":"bc8ff270-76d3-4e8d-a9eb-68a142c03b15","added_by":"auto","created_at":"2020-04-06 17:22:03","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":901018,"visible":true,"origin":"","legend":"Kaplan-Meier survival curves of TLPD vs. OPD for PDAC treatment. (A) Cumulative RFS before matching. (B) Cumulative OS before matching. (C) Cumulative RFS after matching. (D) Cumulative OS after matching. RFS: recurrence-free survival, OS: overall survival.","description":"","filename":"Figure02.jpg","url":"https://assets-eu.researchsquare.com/files/rs-20225/v1/Figure02.jpg"},{"id":845385,"identity":"8516ba03-7481-4aee-9628-b3e76dfb415b","added_by":"auto","created_at":"2020-04-06 17:22:04","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":2260905,"visible":true,"origin":"","legend":"Meta-analysis of the pooled data. (A) Operative time. (B) Blood loss. (C) Transfusion. (D) Hospital stay. (E) Morbidity. (F) Major complications. (G) minor complications. (H) Mortality. (I) Tumor size. (J)Retrieved lymph nodes. (K) R0 rate.","description":"","filename":"Figure03.jpg","url":"https://assets-eu.researchsquare.com/files/rs-20225/v1/Figure03.jpg"},{"id":13497078,"identity":"a6967d22-8af5-4a2d-9bdc-a03a1c3ccdac","added_by":"auto","created_at":"2021-09-16 22:52:15","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2032761,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-20225/v1/b73b514e-8db5-48a7-abdf-22c387b61540.pdf"},{"id":845382,"identity":"b70ec880-c3cf-4389-bcc9-2c533c9c6778","added_by":"auto","created_at":"2020-04-06 17:22:03","extension":"doc","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":73728,"visible":true,"origin":"","legend":"","description":"","filename":"PRISMAChecklist.doc","url":"https://assets-eu.researchsquare.com/files/rs-20225/v1/PRISMA Checklist.doc"}],"financialInterests":"","formattedTitle":"Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis with meta-analysis","fulltext":[{"header":"Background","content":" \u003cp\u003ePancreatic duct adenocarcinoma (PDAC) is currently the fourth leading cause of cancer-related deaths in developed countries and may rank second by the year 2030 [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e, \u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e]. Surgical resection is considered the only method to radically cure this type of cancer [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. The surgical extent depends on the tumor location: left-sided PDAC should be treated by subtotal or distal pancreatectomy (DP), and PDAC on the pancreatic head are amendable to pancreaticoduodenectomy (PD). Minimally invasive surgery (MIS), characterized by laparoscopic interventions, have become the standard of care for many surgical procedures across different specialties. The selection of MIS is the professional objective of surgeons and the most acceptable treatment for patients [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. However, total laparoscopic PD (TLPD) for PDAC is still in its infancy due to the complexity of the operation and the steep learning curve required for its introduction [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. The Miami International Evidence-based Guidelines suggested that TLPD should be exclusive to experienced surgeons in high-volume centers [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. TLPD concerns included the safety, since it is arguably the most complex pancreatic operation, and of oncologic efficacy when performed on patients with PDAC [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. Therefore, the role of TLPD in the setting of PDAC is less established and quality data are limited [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. In this study, we evaluated the feasibility and safety of TLPD by comparing their short- and long-term clinical outcomes with those of open PD (OPD) through a propensity score-matched analysis to minimize selection bias based on our more than 15\u0026nbsp;years of experience performing laparoscopic pancreatic surgeries [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. In addition, a rapid systematic review with a meta-analysis was conducted to further determine whether TLPD are an acceptable alternative to open surgery for PDAC treatment.\u003c/p\u003e "},{"header":"Methods","content":" \u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eStudy design and definitions\u003c/h2\u003e \u003cp\u003eThis study was approved by the Ethics Committee of Zhejiang University. Written consent was obtained from every patient prior to surgery. Patients diagnosed with PDAC from January 2013 to January 2019 were identified from our prospectively maintained pancreatic database. The diagnosis of PDAC was based primarily on preoperative imaging, specifically abdominal computed tomography or magnetic resonance imaging. When we initially conducted PD laparoscopically, an epigastric auxiliary incision was sometimes made to facilitate the reconstruction and help us to accumulate experience, which was referred to as a laparoscopic assisted PD (LAPD). TLPDs are characterized by intracorporeal anastomoses without an auxiliary incisions. Cases of LAPD were excluded from this study since TLPD preserve the integrity of the abdominal wall which would create a minimally-invasive advantage for TLPD over LAPD. We routinely conducted multi-disciplinary team treatment models for every major abdominal surgery during which the decision to perform either laparoscopic or open approaches would be discussed followed by a presentation to patients and their families to make a final decision.\u003c/p\u003e \u003cp\u003eTo minimize selection biases, a 1:1 propensity score matching (PSM) was performed using a logistic regression model and included the following covariates: age, sex, ASA grade, tumor size, and combined resection. Data on patient demographics, clinical presentation, surgical outcomes, tumor characteristics, lymph node status, resection margins, and long-term oncologic outcomes were compared. Postoperative pancreatic fistulas (POPF) were defined and classified according to the 2016 updated International Study Group on Pancreatic Surgery definitions, in which Grade B and C were considered \u0026ldquo;clinically relevant (CR-POPF)\u0026rdquo; [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. Complications were recorded using the Clavien\u0026ndash;Dindo classification system [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. Oncologic outcomes were analyzed for all patients, including tumor size (maximum dimensions; cm), total number of lymph nodes (LNs), and margin status. The LN ratio was defined as the number of ([the number of affected LNs/total number of LNs]\u0026thinsp;\u0026times;\u0026thinsp;100%). Resection margins were considered negative (R0) when no tumor was evident along the transection surface [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. Tumor recurrence was graded as locoregional, extrapancreatic, and multiple. Locoregional recurrences included tumors in adjacent organs, pancreatic remnants, or locoregional LNs. Extrapancreatic recurrences included peritoneal, distant lymphatic or hematogenous metastases. Radiologic evidence of intra-abdominal soft tissue around the operative site and/or distant metastases was defined as tumor recurrence. Recurrence-free survival (RFS) was defined as the time between surgery and diagnosis of recurrence or censoring. Overall survival (OS) was defined as the time between the date of surgery and the date of death from any cause or censoring.\u003c/p\u003e \u003c/div\u003e \n\u003ch2\u003eOperative Procedure\u003c/h2\u003e\n \u003cp\u003eDetails of the various operative procedures were previously described [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e, \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. Five ports were inserted for the surgeon and the assistant. The surgical extension and protocol was the same as in open surgeries. The lymphadenectomy included the following LN stations: 5 (suprapyloric), 6 (infrapyloric), 8a (common hepatic artery), 12b-c (along the bile duct and cystic duct), 13a-b (along the head of the pancreas), 14a-b (along the right lateral side of superior mesenteric artery), and 17a-b (along the anterior face of the head of the pancreas). Retroperitoneal soft-tissue was completely removed. The intracorporeal Child\u0026rsquo;s approach was used for the reconstruction along the same principles of in pancreaticojejunostomy (PJ). An end-to-side PJ was conducted as long as a maximum diameter of 2\u0026nbsp;mm was attained at the pancreatic duct, in spite of the difficulty in identification, while the duct-to-mucosa PJ could be utilized in cases where the pancreatic ducts were over a diameter of 2\u0026nbsp;mm. All specimens and their margins were routinely sent for intra-operative frozen section examinations.\u003c/p\u003e \n\u003ch2\u003eMeta-analysis\u003c/h2\u003e\n \u003cp\u003eWe searched PubMed, EMBASE, and the Cochrane Library for literature comparing TLPD vs. OPD outcomes in the treatment of PDAC up to December 2019 and broadened the search range by browsing the references of retrieved articles. The following search terms were used: \u0026ldquo;minimally invasive,\u0026rdquo; \u0026ldquo;laparoscopy,\u0026rdquo; \u0026ldquo;Whipple,\u0026rdquo; \u0026ldquo;pancreaticoduodenectomy,\u0026rdquo; \u0026ldquo;pancreatic ductal adenocarcinoma,\u0026rdquo; and \u0026ldquo;pancreatic cancer.\u0026rdquo; The language of the articles was limited to English. Review articles, overlap authors or centers, and articles without adequate statistical data were excluded. All searched articles were reviewed by three authors (K.C., Y.P., and C.J.H), and disagreement was resolved via discussion. The Newcastle\u0026ndash;Ottawa Quality Assessment Scale (NOS) was utilized to evaluate the quality of the included studies.\u003c/p\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003eStatistical analysis\u003c/h2\u003e \u003cp\u003eWe used SPSS version 23.0 (IBM Corp., Armonk, NY) to perform all statistical analysis. Analysis was performed in the intention to treat population, that is, all patients who received the allocated intervention. Continuous variables are expressed as mean and standard deviation (SD) when the distribution was considered normal, and otherwise using the median, and range. Categorical variables are expressed as absolute numbers and percentages. The Student \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003et\u003c/span\u003e test or the Mann\u0026ndash;Whitney \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eU\u003c/span\u003e test was used for the comparison of continuous variables and the chi-square Chi-square test or the Fisher exact test for categorical variables, depending on the conditions of application. Survival rates and comparisons were estimated by the Kaplan\u0026ndash;Meier survival curves and the log-rank test. All reported \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e values are 2-sided. Values of \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.05 were considered to indicate statistically significant differences. For the meta-analysis, Review Manager ver. 5.1 (Nordic Cochrane Center, Copenhagen, Denmark) was used. The effect size was calculated using odds ratio (OR) for dichotomous variables and weighted mean difference (WMD) with 95% confidence interval (CI) for continuous data. To account for clinical heterogeneity, which refers to diversity in a sense that is relevant for clinical situations, we used the random effects model based on DerSimonian and Laird\u0026rsquo; s method. \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.05 was considered statistically significant.\u003c/p\u003e \u003c/div\u003e "},{"header":"Results","content":" \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003ePatient selection and clinicopathological characteristics\u003c/h2\u003e \u003cp\u003eDuring the study period, 276 patients (TLPD: 98 and OPD: 178) meeting the inclusion and exclusion criteria were selected. After PSM, 89 patients in the TLPD group and 89 patients in the OPD group were included in the final analysis. A flow chart of patient selection is shown in Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e. Baseline characteristics of patients in both groups are shown in Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e. There were no statistically significant baseline characteristic differences between the two groups. PSM enabled better comparability between the two groups.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cdiv class=\"SimplePara\"\u003eDemographics, clinical characteristics before and after matching of TLPD vs. OPD.\u003c/div\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cdiv class=\"SimplePara\"\u003eVariable\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003eAll patients\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c7\" namest=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003ePropensity-matched patients\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;98)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;178)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eAge (years)\u003csup\u003ea\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e63.2\u0026thinsp;\u0026plusmn;\u0026thinsp;9.3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e62.5\u0026thinsp;\u0026plusmn;\u0026thinsp;9.5\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.54\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e62.7\u0026thinsp;\u0026plusmn;\u0026thinsp;7.6\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e62.4\u0026thinsp;\u0026plusmn;\u0026thinsp;8.2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.80\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eGender (Male: Female)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e63:35\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e111:67\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.75\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e58:31\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e58:31\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e1.00\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eBMI (kg/m\u003csup\u003e2\u003c/sup\u003e)\u003csup\u003ea\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e22.1\u0026thinsp;\u0026plusmn;\u0026thinsp;2.6\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e22.2\u0026thinsp;\u0026plusmn;\u0026thinsp;3.1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.88\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e22.1\u0026thinsp;\u0026plusmn;\u0026thinsp;2.5\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e22.4\u0026thinsp;\u0026plusmn;\u0026thinsp;3.0\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.44\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eASA classification (I:II:III)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e42:49:7\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e80:92:6\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.40\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e41:46:2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e38:49:2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.87\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePresence of comorbidity (Yes:No)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e44:54\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e81/97\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.92\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e40:49\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e42:47\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.76\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eHypertension\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e22\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e60\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e19\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e29\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eDiabetes mellitus\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e16\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e27\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e14\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e14\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eCardiovascular\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e7\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e5\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePulmonary\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e5\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e6\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e5\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eHepatic\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e4\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e0\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eOthers\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e6\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eNeoadjuvant chemotherapy (%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e4 (4.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e13 (7.3%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.29\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e3 (3.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e7 (7.9%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.19\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"7\"\u003ea: values were showed as mean (standard deviation) and tested by Student\u0026rsquo;s \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003et\u003c/span\u003e test; b: values were showed median (range) and tested by Mann-Whitney \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eU\u003c/span\u003e test. \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eBMI\u003c/span\u003e body mass index, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eASA\u003c/span\u003e American Society of Anesthesiologists.\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003c/div\u003e \n\u003ch2\u003eSurgical Data And Postoperative Outcomes\u003c/h2\u003e\n \u003cp\u003eSurgical data and postoperative outcomes are summarized in Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e. For the 98 TLPD cases, conversion to open surgery was necessary in 8 (8.2%) because of a severe adhesion caused by historical abdominal surgery (n\u0026thinsp;=\u0026thinsp;1), intraoperative uncontrollable bleeding from the branches of major vessels (superior mesenteric artery, n\u0026thinsp;=\u0026thinsp;2; gastroduodenal artery, n\u0026thinsp;=\u0026thinsp;1; portal vein, n\u0026thinsp;=\u0026thinsp;1), suspicious vascular invasion to achieve safe margins (n\u0026thinsp;=\u0026thinsp;2); and acidosis due to a long lasting pneumoperitoneum (n\u0026thinsp;=\u0026thinsp;1). Before PSM, the OPD group had a higher proportion of combined resections (6.1% vs. 11.2%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.16), which were eliminated by PSM (5.6% vs. 5.6%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;1.00). TLPD showed longer operative times than OPD before PSM (425.5\u0026thinsp;\u0026plusmn;\u0026thinsp;75.0 vs. 382.6\u0026thinsp;\u0026plusmn;\u0026thinsp;85.4\u0026nbsp;min, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01), and the difference was even more obvious after PSM (426.1\u0026thinsp;\u0026plusmn;\u0026thinsp;75.3 vs. 370.5\u0026thinsp;\u0026plusmn;\u0026thinsp;85.3\u0026nbsp;min, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01). TLPD showed less blood loss (before PSM, 280 [120\u0026ndash;900] vs. 400 [200\u0026ndash;1500] mL, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01; after PSM, 260 [120\u0026ndash;900] vs. 400 [200\u0026ndash;1200) mL, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01], and fewer blood transfusions (before PSM, 16.3% vs. 30.3%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.01; after PSM, 15.7% vs. 28.1%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.04) before and after PSM. The median hospital stay (after PSM, 13 [8\u0026ndash;69] vs. 19 [11\u0026ndash;52] days, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01) was longer in the OPD group than in the LPD group. Two in-hospital mortalities were noted: each group had one severe postoperative pancreatic fistula (POPF), and the patients died of multisystem organ failure secondary to sepsis. After PSM, 31 patients in the OPD group and 17 in the TLPD group experienced postoperative complications (after PSM, 20.2% vs. 33.7%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.02). For specific complications, delayed gastric emptying (DGE) (5.6% vs. 11.2%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.18) and pulmonary complications (1.1% vs. 5.6%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.11) were more frequent in the OPD group; however, the difference between the groups did not attain statistical significance. Morbidity in the OPD group was serious according to the Clavien\u0026ndash;Dindo classification, but the difference also did not attain statistical significance (\u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.12).\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cdiv class=\"SimplePara\"\u003eSurgical data and postoperative outcomes before and after matching of TLPD vs. OPD.\u003c/div\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cdiv class=\"SimplePara\"\u003eVariable\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003eAll patients\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c7\" namest=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003ePropensity-matched patients\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;98)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;178)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD(n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eOperative time (min)\u003csup\u003ea\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e425.5\u0026thinsp;\u0026plusmn;\u0026thinsp;75.0\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e382.6\u0026thinsp;\u0026plusmn;\u0026thinsp;85.4\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e426.1\u0026thinsp;\u0026plusmn;\u0026thinsp;75.3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e370.5\u0026thinsp;\u0026plusmn;\u0026thinsp;85.3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eEstimated blood loss (mL)\u003csup\u003eb\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e280 (120\u0026ndash;900)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e400 (200\u0026ndash;1500)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e260 (120\u0026ndash;900)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e400 (200\u0026ndash;1200)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eRBC transfusion (%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e16 (16.3%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e54 (30.3)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e14 (15.7%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e25 (28.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e0.04\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eCombined resection\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e6 (6.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e20 (11.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.16\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e5 (5.6%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e5 (5.6%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e1.00\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePostoperative hospital stay (days)\u003csup\u003eb\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e13.5 (8\u0026ndash;69)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e19 (9\u0026ndash;72)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e13 (8\u0026ndash;69)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e19 (11\u0026ndash;52)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eOverall morbidity (n, %)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e20 (20.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e62 (34.8%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e17 (19.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e31 (33.7%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e0.02\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eCR-POPF\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e11 (11.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e29 (16.3%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.24\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e11 (12.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e15 (16.8%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.40\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eDelayed gastric emptying\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e5 (5.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e16 (9.0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.24\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e5 (5.6%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e10 (11.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.18\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eHemorrhage\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e4 (4.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e17 (9.6%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.10\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e4 (4.5%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e8 (9.0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.23\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eBile leak\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e2 (2.0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e6 (3.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.41\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e2 (2.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e3 (3.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.50\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eWound infection\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e0 (0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e3 (1.7%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.27\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e0 (0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e1 (1.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.50\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eLymphorrhea\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e0 (0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e2 (1.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.42\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e0 (0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e2 (2.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.25\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePulmonary complications\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e2 (2.0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e13 (7.3%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.07\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e1 (1.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e5 (5.6%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.11\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eReoperation (%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e5 (5.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e13 (7.3%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.48\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e4 (4.5%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e6 (6.7%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.52\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eClavien-Dindo classification\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.05\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.12\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eI-II\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e9\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e28\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e7\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e15\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eIII-IV\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e10\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e33\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e9\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e15\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eV (90-day mortality)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"7\"\u003ea: values were showed mean (standard deviation) and tested by Student\u0026rsquo;s \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003et\u003c/span\u003e test; b: values were showed median (range) and tested by Mann-Whitney \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eU\u003c/span\u003e test. RBC: red blood cell.\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \n\u003ch2\u003ePathology Examination And Oncological Outcomes\u003c/h2\u003e\n \u003cp\u003ePathology examination outcomes are listed in Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e. Before PSM, the TLPD group had smaller tumor sizes. After PSM, pathological examination revealed that tumor size, pT-stage, and pN-stage were well matched between the two groups. The TLPD group was associated with a significantly higher number of harvested LNs than the OPD group (21.9\u0026thinsp;\u0026plusmn;\u0026thinsp;6.6 vs. 18.9\u0026thinsp;\u0026plusmn;\u0026thinsp;5.4, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01), whereas the radical R0 resection rates, positive LNs, and LN ratios were comparable between the two groups.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cdiv class=\"SimplePara\"\u003ePathology examination before and after matching of TLPD vs. OPD.\u003c/div\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cdiv class=\"SimplePara\"\u003eVariable\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003eAll patients\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c7\" namest=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003ePropensity-matched patients\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;98)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;178)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eTumor size\u003csup\u003ea\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.0\u0026thinsp;\u0026plusmn;\u0026thinsp;0.9\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.5\u0026thinsp;\u0026plusmn;\u0026thinsp;1.2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.0\u0026thinsp;\u0026plusmn;\u0026thinsp;0.9\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.0\u0026thinsp;\u0026plusmn;\u0026thinsp;1.0\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.74\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eDifferentiation\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.88\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.52\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eWell\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e31\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e62\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e29\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e35\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eModerate\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e41\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e72\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e35\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e35\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePoor\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e26\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e44\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e25\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e19\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eR0 resection (%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e88 (89.8%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e148 (83.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.13\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e82 (92.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e78 (87.6%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.32\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eRetrieved lymph node\u003csup\u003ea\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e21.8\u0026thinsp;\u0026plusmn;\u0026thinsp;6.5\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e18.9\u0026thinsp;\u0026plusmn;\u0026thinsp;5.7\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e21.9\u0026thinsp;\u0026plusmn;\u0026thinsp;6.6\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e18.9\u0026thinsp;\u0026plusmn;\u0026thinsp;5.4\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e\u0026lt;\u0026thinsp;0.01\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePositive lymph node\u003csup\u003eb\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e1 (0\u0026ndash;14)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e1 (0\u0026ndash;11)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.98\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e1 (0\u0026ndash;14)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e0 (0\u0026ndash;10)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.84\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eLymph node ratio\u003csup\u003eb\u003c/sup\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.3 (0\u0026ndash;50)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.5 (0\u0026ndash;50)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.48\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e3.1 (0\u0026ndash;50)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e0 (0\u0026ndash;50)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.71\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePathologic T stage\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.24\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.89\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eT1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e10\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e24\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e12\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e15\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eT2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e72\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e113\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e64\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e62\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eT3\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e16\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e41\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e13\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e12\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003ePathologic N stage\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.22\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.48\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eN0\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e45\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e87\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e42\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e45\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eN1\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e45\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e66\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e40\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e34\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eN2\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e8\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e25\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e7\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e11\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"7\"\u003ea: values were showed as mean (standard deviation) and tested by Student\u0026rsquo;s \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003et\u003c/span\u003e test; b: values were showed median (range) and tested by Mann-Whitney \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eU\u003c/span\u003e test.\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eThe oncological outcomes are summarized in Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e. The median follow-up times were 25 (10\u0026ndash;58) months and 23 (10\u0026ndash;83) months in the TLPD and OPD groups, respectively. Before PSM, recurrence occurred in 70 patients (71.4%) in the TLPD group including 19 (27.1%) locoregional, 33 (47.1%) extrapancreatic, and 18 (25.7%) combined locoregional/extrapancreatic recurrences, and 138 patients (77.5%) in the OPD group including 31 (17.4%) locoregional, 57 (32.0%) extrapancreatic, and 50 (28.1%) multiple recurrences, without statistically significant difference between the two groups (\u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.26). There were also no statistically significant differences in recurrence patterns (\u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.31) between the two groups. However, statistically improved recurrence-free and overall survival outcomes (before PSM, median survival, 95% CI: 26 [20.4\u0026ndash;31.6] vs. 19 [16.7\u0026ndash;21.3] months, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.02) were identified in the TLPD group as shown in Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e, and Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003eA and Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003eB. After PSM, there was no difference in any of the values, indicating the procedures have equivalent oncologic outcomes. Although the TLPD group showed a slightly longer median survival time than the OPD group (25 [19.4\u0026ndash;30.6] vs. 21 [17.4\u0026ndash;24.6] months), there was no statistically significant difference in regard to survival outcomes between the two groups (\u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.29) as shown in Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e and Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003eC Fig.\u0026nbsp;\u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003eD.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cdiv class=\"SimplePara\"\u003eOncological outcomes before and after matching of TLPD vs. OPD.\u003c/div\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cdiv class=\"SimplePara\"\u003eVariable\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003eAll patients\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"3\" nameend=\"c7\" namest=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003ePropensity-matched patients\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;98)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;178)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eTLPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003eOPD (n\u0026thinsp;=\u0026thinsp;89)\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"BoldItalic\" class=\"BoldItalic\" name=\"Emphasis\"\u003ep\u003c/span\u003e \u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003evalue\u003c/span\u003e\u003c/div\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eRecurrence\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e70 (71.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e138 (77.5%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.26\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e62 (69.7%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e66 (74.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.51\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eInitial sites of recurrence\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.31\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.61\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eLocoregional\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e19 (27.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e31 (17.4%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e15 (24.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e16 (24.2%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eExtrapancreatic\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e33 (47.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e57 (32.0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e31 (50.0%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e27 (40.9%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eMultiple\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e18 (25.7%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e50 (28.1%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e16 (25.8%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e23 (34.8%)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eRFS\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e0.04\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.29\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003e1-year\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e62.5%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e49.1%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e62.1%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e54.3%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003e2-year\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e38.7%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e28.2%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e39.5%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e31.5%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003e3-year\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e20.6%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e19.2%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e21.8%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e22.7%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eOS\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cdiv class=\"SimplePara\"\u003e\u003cspan type=\"Bold\" class=\"Bold\" name=\"Emphasis\"\u003e0.02\u003c/span\u003e\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cdiv class=\"SimplePara\"\u003e0.29\u003c/div\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003e1-year\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e88.5%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e68.9%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e87.4%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e71.6%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003e2-year\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e53.9%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e37.8%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e52.4%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e44.0%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003e3-year\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e31.8%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e22.1%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e33.3%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e27.3%\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cdiv class=\"SimplePara\"\u003eMedian survival (95% CI)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cdiv class=\"SimplePara\"\u003e26 (20.4\u0026ndash;31.6)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cdiv class=\"SimplePara\"\u003e19 (16.7\u0026ndash;21.3)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cdiv class=\"SimplePara\"\u003e25(19.4\u0026ndash;30.6)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cdiv class=\"SimplePara\"\u003e21(17.4\u0026ndash;24.6)\u003c/div\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"7\"\u003e\u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eRFS\u003c/span\u003e recurrence-free survival, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eOS\u003c/span\u003e overall survival, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003eCI\u003c/span\u003e confidence interval.\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003c/p\u003e \n\u003ch2\u003eOutcomes Of The Systematic Review And Meta-analysis\u003c/h2\u003e\n \u003cp\u003eThe initial search strategy retrieved 968 English publications. Of these, 86 articles were selected based on their titles and abstracts, and a full examination of the texts was performed. Seventy-eight papers were excluded since they contained pancreatic head and periampullary malignancies in addition to PDAC. A further 4 studies were excluded due to inadequate statistical data [\u003cspan additionalcitationids=\"CR16 CR17\" citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. A study evaluating LAPD instead of TLPD for PDAC treatment was also excluded [\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e]. One study reported the data from the National Cancer Database (NCDB) [\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e], which compiled cancer registry data in the U.S. and Puerto Rico. Due to the risk of overlapping data with other included studies, this study was also excluded. Finally, only two articles remained [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e], each receiving 8 Newcastle\u0026ndash;Ottawa (NOS) points. Both articles represent the American experience. A flow chart of the search strategies is illustrated in Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e. Including the present data (after PSM), there were 751 participants in three studies (255 patients in the TLPD group and 496 patients in the OPD group).\u003c/p\u003e \u003cp\u003eThe conversion rates of the two included studies were 6.5% (7/108) [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e] and 24.1% (14/58) [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e], respectively. Although TLPD seemed to have longer durations, the meta-analysis of operative times showed no significant differences between the two groups (WMD\u0026thinsp;=\u0026thinsp;62.78\u0026nbsp;min, 95% CI: -17.86 to 143.42, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.13; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eA). However, the intraoperative blood loss was lower in TLPD than in OPD (WMD = -256.94\u0026nbsp;mL, 95% CI: -461.87 to -52.01, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.01; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eB), as were the transfusion rates (OR\u0026thinsp;=\u0026thinsp;0.45, 95% CI: 0.32 to 0.66, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eC). The pooled data further showed shorter lengths of hospital stays with respect to TLPD (WMD = -4.59 days, 95% CI: -6.70 to -2.48, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eD). In addition, the pooled analysis indicated that the rate of overall morbidity was significantly lower in the TLPD group (OR\u0026thinsp;=\u0026thinsp;0.51, 95% CI: 0.36 to 0.70, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eE). Separate analyses were performed by dividing the overall morbidity into major and minor complications according to the Clavien\u0026ndash;Dindo classification, in which major complications were graded from III to V and minor ones were graded I and II [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e]. We found that both major (OR\u0026thinsp;=\u0026thinsp;0.55, 95% CI: 0.35 to 0.88, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.01; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eF) and minor complications (OR\u0026thinsp;=\u0026thinsp;0.66, 95% CI: 0.46 to 0.95, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eG) were significantly lower in the TLPD group. However, our meta-analysis showed there was no statistically significant difference in mortality (OR\u0026thinsp;=\u0026thinsp;0.65, 95% CI: 0.21 to 2.06, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.46; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eH) between the two groups. For oncologic outcomes, results showed comparable tumor sizes (WMD = -0.16\u0026nbsp;cm, 95% CI: -0.53 to 0.21, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.40; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eI). The pooled data of retrieved LNs showed that the number of LNs from TLPD was greater than that of the open group (WMD\u0026thinsp;=\u0026thinsp;4.19, 95% CI: 0.64 to 7.75, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.02; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eJ). Pooling results indicated a comparable R0 rate between the groups (OR\u0026thinsp;=\u0026thinsp;1.23, 95% CI: 0.82 to 1.86, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.32; Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eK). Both studies reported no significant difference in the survival rates between the two groups during their follow-up times. However, quantitative analyses of long-term survival outcomes were not performed due to limited data.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e "},{"header":"Discussion","content":" \u003cp\u003ePancreatectomy with lymphadenectomy remains the first-line treatment option for early- and intermediate-stage PDAC. Although laparoscopic DP have become important options for all indications including PDAC on pancreatic bodies and tails [\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e], approaching PD laparoscopically for diseases on pancreatic heads were less frequent owing to the intricacy of the dissection and the complexity of the pancreatoenteric and biliodigestive anastomoses [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e]. This study suggested that TLPD for PDAC were technically feasible and safe. TLPD are longer operations for PDAC treatment than OPD but exhibit clear benefits of less blood loss and shorter hospitalization. More importantly, we found TLPD were associated with lower morbidities than open surgery for PDAC treatments. In addition, laparoscopic procedures appear to hold potential advantages in terms of R0 resections and retrieved LNs. The meta-analysis further confirmed our short-term surgical outcomes. Nevertheless, no statistically significant differences were identified between laparoscopic and open procedures for the treatment of PDAC in the long-term oncological outcomes of recurrence patterns and survival.\u003c/p\u003e \u003cp\u003eThe prolonged operative time in TLPD is an obvious disadvantage. Our initial TLPD for PDAC lasted for nearly 600 minutes [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. Currently, this can be completed in approximately 300\u0026ndash;350 minutes [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. Kendrick et al., in one of the largest single series currently available, described their initial TLPD duration to be 460\u0026nbsp;min, which improved to 320\u0026nbsp;min after approximately 50 cases [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e]. Stauffer et al., reported a median operative time of 518\u0026nbsp;min, which was significantly longer than that in open surgery (140\u0026nbsp;min) [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. The learning curve can be overcome in high volume centers, with average TLPD operative times decreasing to less than 400\u0026nbsp;min [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]. However, due to tumor biology and the aggressiveness of the disease process, TLPD for PDAC treatments are not commonly performed making it difficult to overcome the associated learning curve [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]. Although none of studies identified adverse outcomes, a recent study from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) demonstrated that longer operative times were independently associated with worse perioperative outcomes after pancreatic resections [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e]. Therefore, we believe long duration is a definite disadvantage of TLPD for PDAC treatments.\u003c/p\u003e \u003cp\u003eIn this ITT analysis, the conversion rates were 8.2% (8/98) for all TLPD cases. We found that the conversions generally were due to hemorrhages that were difficult to control or had suspected vessel involvement, which was similar to other publications of TLPD for PDAC treatment [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Although there was less overall blood loss, there were still 4 conversions for intraoperative uncontrollable bleeding in this TLPD group. In fact, the multicenter LEOPARD-2 trial was stopped prematurely due to safety concerns of higher mortalities in the LPD group mainly because of intraoperative bleeding [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. We believe that part of the reason that PDAC frequently induces substantial pancreatic inflammation in the pancreatic remnant is because it is harder to resect due to pronounced adhesions to the surrounding tissues or infiltrations of the portal vein. Portomesenterical vein involvement is a common clinical finding in PDAC, but is a situation that is frequently difficult to diagnose prior to surgery [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. The rate of venous involvement ranges from 26 to 85% in the literature [\u003cspan additionalcitationids=\"CR31\" citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e]. Portomesenteric vein resection is a mean of achieving complete tumor clearance. However, researchers strongly recommend that venous resection during TLPD should only be performed by surgeons with considerable TLPD experience with TLPD and proficiency in open vascular resection [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e, \u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e]. Therefore, approaching appropriate cases like no vessel involvement or severe adhesions laparoscopically in the learning curve would reduce conversion helping to shorten operative time and further reduce bleeding [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eThe most important concern regarding TLPD for PDAC treatments is the patient\u0026rsquo;s safety. We found less postoperative morbidities in TLPD than in OPD (after PSM, 19.1% vs. 33.7%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.02). Furthermore, the meta-analysis indicated not only overall less morbidities in TLPD group, but major and minor complications were also less in the TLPD group when dividing overall complications into major and minor ones according to the Clavien\u0026ndash;Dindo classification. POPF is a frequent event and the best management for the pancreatic stump is still under debate with our results revealing no significant differences between the two groups. The anastomoses performed during LPD are the main topic of concern. However, there is no consensus on the best method of anastomosis after PD (e.g., pancreaticojejunostomy or pancreaticogastrostomy, duct-to-mucosa or invagination anastomosis, etc.) [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. The reported methods in open surgery now can be meticulously performed laparoscopically [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e]. No appreciable differences were noted between groups for POPFs because the true risk factors of significant POPFs have been recognized as soft pancreatic parenchyma, high-risk disease pathology, and small pancreatic duct size, rather than the anastomosis method [\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e, \u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e]. We argue that the main contributors of lower morbidity in TPLD were reduced delayed gastric emptying (DGE) (after PSM, 5.6% vs. 11.2%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.18) and pulmonary complications (after PSM, 1.1% vs. 5.6%, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.11). DGE is not life threatening, but can have significant consequences such as patient discomfort, prolonged hospital stays, increased hospital costs, diminished nutritional status, and delays in initiation of adjuvant therapy [\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e, \u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e]. According to the literature, the pathogenesis of DGE is multifactorial and given the improved access and visualization of the laparoscopic approach, as well as the meticulous attention to techniques, potential reasons for this advantage include [\u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e, \u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e]: 1) laparoscopic surgery has less influence on the peripheral organs and peritoneum leading to less seroperitoneum helping to alleviate of gastric dysrhythmias, 2) ameliorative pyloric or antral ischemia due to reservation of small vessels, and 3) mitigant pylorospasms secondary to denervation of the stomach and duodenum or jejunum. As one of the most complex abdominal surgeries, PD involves multiple systems and would cause more medical complications than other surgeries. It is well known that major abdominal surgery has a detrimental effect on respiratory function, and this is particularly true in upper abdominal surgeries. In general, open procedures are reported to portend a higher risk of pleural effusions, pulmonary infections, and atelectasis than do minimally invasive ones [\u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e, \u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eOncologic safety and efficacy should be clearly demonstrated prior to a wide application of a new surgical approach. The long-term survival outcomes of MIS for common malignancies have conflicting results [\u003cspan additionalcitationids=\"CR45\" citationid=\"CR44\" class=\"CitationRef\"\u003e44\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR46\" class=\"CitationRef\"\u003e46\u003c/span\u003e], leading to a constant controversy over MIS for cancer treatments. Oncological surgery requires a radical resection, adequate lymphadenectomy, and meticulous \u0026lsquo;no-touch\u0026rsquo; dissection as it may prevent seeding and tumor cell dissemination. R0 resection is frequently referred to as a crucial factor, which is deemed the only hope for cure [\u003cspan citationid=\"CR47\" class=\"CitationRef\"\u003e47\u003c/span\u003e]. Tactile evaluation of tissue is not possible during laparoscopy and was presumed to lead to inadequate surgical margins. Nevertheless, our study revealed that the R0 resection of TLPD are comparable to those of open surgery. In addition, our data showed the retrieved LNs of TLPD were not inferior to those of OPD, or even superior to OPD for lymphadenectomy (after PSM, 21.9\u0026thinsp;\u0026plusmn;\u0026thinsp;6.6 vs. 18.9\u0026thinsp;\u0026plusmn;\u0026thinsp;5.4, \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.01). These findings were further confirmed by the rapid meta-analysis. The advantages of high-resolution imaging, multi-dimensional vision, and meticulous manipulation help to facilitate lymphadenectomy. A single-center study conducted by Asbun and Stauffer, reported a comparable long-term survival of 1-, 2-, 3-, 4-, and 5-years for OPDs (68, 40, 24, 17, and 15%) and for TLPDs (67, 43, 43, 38, and 32%), respectively [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e]. Kuesters et al., conducted a series of LAPD, also reported a comparable 5-year survival rate between LAPD (20%) and OPD (14%) for PDAC [\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e]. Croome et al., recorded that the progression-free survival was longer in TLPD [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. In this analysis, we found patients' survival in the TLPD group was superior to those in the OPD group before PSM (RFS: \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.04, OS: \u003cspan type=\"Italic\" class=\"Italic\" name=\"Emphasis\"\u003ep\u003c/span\u003e\u0026thinsp;=\u0026thinsp;0.02). After PSM, in which tumor size and stage were balanced, the 3-year OS and DFS in the TLPD group were still slightly higher than in the OPD group, but the differences failed to reach statistical significance. We believe our results were credible since PSM established the oncologic equivalence of two surgical techniques. We considered there may be other reasons for such results in addition to more LNs examined in the laparoscopic groups. One hypothesis was that improved recovery after laparoscopic surgery helped to instigate multimodality therapies earlier, thus leading to survival benefits [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. However, a retrospective analysis of the NCDB found that MIS did not improve use or initiation of adjuvant chemotherapy for patients with PDAC [\u003cspan citationid=\"CR48\" class=\"CitationRef\"\u003e48\u003c/span\u003e]. Moreover, the survival impact of the initiation time of adjuvant chemotherapy in patients with resected PDAC remains uncertain since studies showed conflicting results [\u003cspan citationid=\"CR49\" class=\"CitationRef\"\u003e49\u003c/span\u003e, \u003cspan citationid=\"CR50\" class=\"CitationRef\"\u003e50\u003c/span\u003e]. In our opinion, neither procedure is technically superior, but efficiency would largely depend on the techniques of the surgeon. Thus, considering the principles of radical resection, a technically similar oncologic resection could be performed regardless of whether the an open or laparoscopic approach was used.\u003c/p\u003e \u003cp\u003eLimitations of this study include its retrospective design, small sample size, absence of randomization, and short follow-up period. However, given the fact that TLPD for patients with PDAC are associated with novelty and unpredictable risks, the current study enrolled a relatively large number of cases. To overcome the selection bias arising from a lack of randomization, we performed PSM analyses which was deemed as the most effective method to balance the covariates and thus reduce bias in the retrospective studies.\u003c/p\u003e "},{"header":"Conclusions","content":" \u003cp\u003eThe current PSM with meta-analysis demonstrated that TLPD for patients with PDAC was a safe alternative to OPD, as it was associated with less blood loss and a better postoperative recovery in terms of a shorter hospital stay and fewer complications. However, this technique also has the disadvantage of longer operative times. Oncological outcomes of TLPD were not inferior to traditional open procedures. Higher levels of evidence including controlled trials are needed to elucidate clear conclusions.\u003c/p\u003e "},{"header":"Abbreviations","content":"\u003cp\u003ePDAC: pancreatic ductal adenocarcinoma, TLPD: total laparoscopic pancreaticoduodenectomy, LPD: laparoscopic pancreaticoduodenectomy OPD: open pancreaticoduodenectomy, DP: distal pancreatectomy, MIS: minimally invasive surgery, LAPD: laparoscopic assisted pancreaticoduodenectomy, PSM: propensity score matching, ITT: intention-to-treat, ISGPF: International Study Group on Pancreatic Fistula, POPF: postoperative pancreatic fistula, CR-POPF: clinically relevant POPF, RFS: recurrence-free survival, OS: overall survival, PJ: pancreaticojejunostomy, SD: standard deviation, NOS: Newcastle-Ottawa Quality Assessment Scale, OR: odds ratio, WMD: weighted mean difference, CI: confidence interval, NCDB: National Cancer Database, NSQIP: National Surgical Quality Improvement Program, BMI: body mass index, ASA: American Society of Anesthesiologists, RBC: red blood cell.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics approval and consent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was approved by the Ethics Committee of Zhejiang University. Written consent was obtained from every patient prior to surgery.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and materials\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets generated and/or analyzed during the current study are not publicly available due to data privacy according to the license for the current study, but are available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no competing interests.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis research was supported by Scientific and Technological Project of Zhejiang Province (Grant No. LGF20H030009). The funders had no role in study design, data collection and analysis, interpretation of data and preparation of the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors' contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCK, PY and HCJ wrote the manuscript; CK, MYP, YJF, ZRC, ZMZ, WGY, WXF, and CQL performed the operations; PY, HCJ and CQL reviewed the medical records and collected data; MYP and CQL proofread and revised the manuscript; all authors read and approved the final manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNo additional investigators were involved in this research project.\u003c/p\u003e"},{"header":"References","content":" \u003col\u003e\n\u003cli\u003eBray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: \u003cstrong\u003eGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries\u003c/strong\u003e. \u003cem\u003eCA Cancer J Clin \u003c/em\u003e2018, \u003cstrong\u003e12\u003c/strong\u003e(10):21492.\u003c/li\u003e\n\u003cli\u003eRahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM: \u003cstrong\u003eProjecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States\u003c/strong\u003e. \u003cem\u003eCancer Res \u003c/em\u003e2014, \u003cstrong\u003e74\u003c/strong\u003e(11):2913-2921.\u003c/li\u003e\n\u003cli\u003eButturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Dervenis C, Bassi C\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eInfluence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials\u003c/strong\u003e. \u003cem\u003eArch Surg \u003c/em\u003e2008, \u003cstrong\u003e143\u003c/strong\u003e(1):75-83.\u003c/li\u003e\n\u003cli\u003eGawande A: \u003cstrong\u003eTwo hundred years of surgery\u003c/strong\u003e. \u003cem\u003eN Engl J Med \u003c/em\u003e2012, \u003cstrong\u003e366\u003c/strong\u003e(18):1716-1723.\u003c/li\u003e\n\u003cli\u003eAnderson B, Karmali S: \u003cstrong\u003eLaparoscopic resection of pancreatic adenocarcinoma: dream or reality?\u003c/strong\u003e \u003cem\u003eWorld J Gastroenterol \u003c/em\u003e2014, \u003cstrong\u003e20\u003c/strong\u003e(39):14255-14262.\u003c/li\u003e\n\u003cli\u003eEdwin B, Sahakyan MA, Abu Hilal M, Besselink MG, Braga M, Fabre JM, Fernandez-Cruz L, Gayet B, Kim SC, Khatkov IE: \u003cstrong\u003eLaparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference\u003c/strong\u003e. \u003cem\u003eSurgical endoscopy \u003c/em\u003e2017, \u003cstrong\u003e31\u003c/strong\u003e(5):2023-2041.\u003c/li\u003e\n\u003cli\u003eAsbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D'Angelica MI, Balduzzi A, Bassi C, Bjornsson B\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eThe Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection\u003c/strong\u003e. \u003cem\u003eAnn Surg \u003c/em\u003e2020, \u003cstrong\u003e271\u003c/strong\u003e(1):1-14.\u003c/li\u003e\n\u003cli\u003ede Rooij T, Klompmaker S, Abu Hilal M, Kendrick ML, Busch OR, Besselink MG: \u003cstrong\u003eLaparoscopic pancreatic surgery for benign and malignant disease\u003c/strong\u003e. \u003cem\u003eNat Rev Gastroenterol Hepatol \u003c/em\u003e2016, \u003cstrong\u003e13\u003c/strong\u003e(4):227-238.\u003c/li\u003e\n\u003cli\u003eKendrick ML, van Hilst J, Boggi U, de Rooij T, Walsh RM, Zeh HJ, Hughes SJ, Nakamura Y, Vollmer CM, Kooby DA\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eMinimally invasive pancreatoduodenectomy\u003c/strong\u003e. \u003cem\u003eHPB \u003c/em\u003e2017, \u003cstrong\u003e19\u003c/strong\u003e(3):215-224.\u003c/li\u003e\n\u003cli\u003eChen K, Pan Y, Mou YP, Wang GY, Zhang RC, Yan JF, Jin WW, Zhang MZ, Chen QL, Wang XF: \u003cstrong\u003eEvolution of Laparoscopic Pancreatic Resections for Pancreatic and Periampullary Diseases: Perioperative Outcomes of 605 Patients at a High-Volume Center\u003c/strong\u003e. \u003cem\u003eJ Laparoendosc Adv Surg Tech A \u003c/em\u003e2019, \u003cstrong\u003e29\u003c/strong\u003e(9):1085-1092.\u003c/li\u003e\n\u003cli\u003eBassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eThe 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After\u003c/strong\u003e. \u003cem\u003eSurgery \u003c/em\u003e2017, \u003cstrong\u003e161\u003c/strong\u003e(3):584-591.\u003c/li\u003e\n\u003cli\u003eDindo D, Demartines N, Clavien PA: \u003cstrong\u003eClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey\u003c/strong\u003e. \u003cem\u003eAnn Surg \u003c/em\u003e2004, \u003cstrong\u003e240\u003c/strong\u003e(2):205-213.\u003c/li\u003e\n\u003cli\u003eWittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, Sobin LH: \u003cstrong\u003eA uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status\u003c/strong\u003e. \u003cem\u003eCancer \u003c/em\u003e2009, \u003cstrong\u003e115\u003c/strong\u003e(15):3483-3488.\u003c/li\u003e\n\u003cli\u003eZhang MZ, Xu XW, Mou YP, Yan JF, Zhu YP, Zhang RC, Zhou YC, Chen K, Jin WW, Matro E\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eResection of a cholangiocarcinoma via laparoscopic hepatopancreato- duodenectomy: a case report\u003c/strong\u003e. \u003cem\u003eWorld J Gastroenterol \u003c/em\u003e2014, \u003cstrong\u003e20\u003c/strong\u003e(45):17260-17264.\u003c/li\u003e\n\u003cli\u003eSong KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, Park KM, Lee YJ: \u003cstrong\u003eMatched Case-Control Analysis Comparing Laparoscopic and Open Pylorus-preserving Pancreaticoduodenectomy in Patients With Periampullary Tumors\u003c/strong\u003e. \u003cem\u003eAnn Surg \u003c/em\u003e2015, \u003cstrong\u003e262\u003c/strong\u003e(1):146-155.\u003c/li\u003e\n\u003cli\u003eDokmak S, Fteriche FS, Aussilhou B, Bensafta Y, Levy P, Ruszniewski P, Belghiti J, Sauvanet A: \u003cstrong\u003eLaparoscopic pancreaticoduodenectomy should not be routine for resection of periampullary tumors\u003c/strong\u003e. \u003cem\u003eJ Am Coll Surg \u003c/em\u003e2015, \u003cstrong\u003e220\u003c/strong\u003e(5):831-838.\u003c/li\u003e\n\u003cli\u003eChen S, Chen JZ, Zhan Q, Deng XX, Shen BY, Peng CH, Li HW: \u003cstrong\u003eRobot-assisted laparoscopic versus open pancreaticoduodenectomy: a prospective, matched, mid-term follow-up study\u003c/strong\u003e. \u003cem\u003eSurg Endosc \u003c/em\u003e2015, \u003cstrong\u003e29\u003c/strong\u003e(12):3698-3711.\u003c/li\u003e\n\u003cli\u003eBoggi U, Napoli N, Costa F, Kauffmann EF, Menonna F, Iacopi S, Vistoli F, Amorese G: \u003cstrong\u003eRobotic-Assisted Pancreatic Resections\u003c/strong\u003e. \u003cem\u003eWorld J Surg \u003c/em\u003e2016, \u003cstrong\u003e40\u003c/strong\u003e(10):2497-2506.\u003c/li\u003e\n\u003cli\u003eKuesters S, Chikhladze S, Makowiec F, Sick O, Fichtner-Feigl S, Hopt UT, Wittel UA: \u003cstrong\u003eOncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study\u003c/strong\u003e. \u003cem\u003eInt J Surg \u003c/em\u003e2018, \u003cstrong\u003e55\u003c/strong\u003e:162-166.\u003c/li\u003e\n\u003cli\u003eKantor O, Talamonti MS, Sharpe S, Lutfi W, Winchester DJ, Roggin KK, Bentrem DJ, Prinz RA, Baker MS: \u003cstrong\u003eLaparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy\u003c/strong\u003e. \u003cem\u003eAm J Surg \u003c/em\u003e2017, \u003cstrong\u003e213\u003c/strong\u003e(3):512-515.\u003c/li\u003e\n\u003cli\u003eCroome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML: \u003cstrong\u003eTotal laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?\u003c/strong\u003e \u003cem\u003eAnn Surg \u003c/em\u003e2014, \u003cstrong\u003e260\u003c/strong\u003e(4):633-638.\u003c/li\u003e\n\u003cli\u003eStauffer JA, Coppola A, Villacreses D, Mody K, Johnson E, Li Z, Asbun HJ: \u003cstrong\u003eLaparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution\u003c/strong\u003e. \u003cem\u003eSurg Endosc \u003c/em\u003e2017, \u003cstrong\u003e31\u003c/strong\u003e(5):2233-2241.\u003c/li\u003e\n\u003cli\u003eClavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eThe Clavien-Dindo classification of surgical complications: five-year experience\u003c/strong\u003e. \u003cem\u003eAnn Surg \u003c/em\u003e2009, \u003cstrong\u003e250\u003c/strong\u003e(2):187-196.\u003c/li\u003e\n\u003cli\u003ePlotkin A, Ceppa EP, Zarzaur BL, Kilbane EM, Riall TS, Pitt HA: \u003cstrong\u003eReduced morbidity with minimally invasive distal pancreatectomy for pancreatic adenocarcinoma\u003c/strong\u003e. \u003cem\u003eHPB \u003c/em\u003e2017, \u003cstrong\u003e19\u003c/strong\u003e(3):279-285.\u003c/li\u003e\n\u003cli\u003eKendrick ML, Cusati D: \u003cstrong\u003eTotal laparoscopic pancreaticoduodenectomy: feasibility and outcome in an early experience\u003c/strong\u003e. \u003cem\u003eArch Surg \u003c/em\u003e2010, \u003cstrong\u003e145\u003c/strong\u003e(1):19-23.\u003c/li\u003e\n\u003cli\u003eChen K, Pan Y, Liu XL, Jiang GY, Wu D, Maher H, Cai XJ: \u003cstrong\u003eMinimally invasive pancreaticoduodenectomy for periampullary disease: a comprehensive review of literature and meta-analysis of outcomes compared with open surgery\u003c/strong\u003e. \u003cem\u003eBMC Gastroenterol \u003c/em\u003e2017, \u003cstrong\u003e17\u003c/strong\u003e(1):017-0691.\u003c/li\u003e\n\u003cli\u003eMaggino L, Liu JB, Ecker BL, Pitt HA, Vollmer CM, Jr.: \u003cstrong\u003eImpact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database\u003c/strong\u003e. \u003cem\u003eJournal of the American College of Surgeons \u003c/em\u003e2018.\u003c/li\u003e\n\u003cli\u003evan Hilst J, de Rooij T, Bosscha K, Brinkman DJ, van Dieren S, Dijkgraaf MG, Gerhards MF, de Hingh IH, Karsten TM, Lips DJ\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eLaparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial\u003c/strong\u003e. \u003cem\u003eLancet Gastroenterol Hepatol \u003c/em\u003e2019, \u003cstrong\u003e4\u003c/strong\u003e(3):199-207.\u003c/li\u003e\n\u003cli\u003eTeramura K, Noji T, Nakamura T, Asano T, Tanaka K, Nakanishi Y, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S: \u003cstrong\u003ePreoperative diagnosis of portal vein invasion in pancreatic head cancer: appropriate indications for concomitant portal vein resection\u003c/strong\u003e. \u003cem\u003eJ Hepatobiliary Pancreat Sci \u003c/em\u003e2016, \u003cstrong\u003e23\u003c/strong\u003e(10):643-649.\u003c/li\u003e\n\u003cli\u003eCapussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M: \u003cstrong\u003eExtended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy\u003c/strong\u003e. \u003cem\u003eArch Surg \u003c/em\u003e2003, \u003cstrong\u003e138\u003c/strong\u003e(12):1316-1322.\u003c/li\u003e\n\u003cli\u003eBachellier P, Nakano H, Oussoultzoglou PD, Weber JC, Boudjema K, Wolf PD, Jaeck D: \u003cstrong\u003eIs pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?\u003c/strong\u003e \u003cem\u003eAm J Surg \u003c/em\u003e2001, \u003cstrong\u003e182\u003c/strong\u003e(2):120-129.\u003c/li\u003e\n\u003cli\u003eTseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003ePancreaticoduodenectomy with vascular resection: margin status and survival duration\u003c/strong\u003e. \u003cem\u003eJ Gastrointest Surg \u003c/em\u003e2004, \u003cstrong\u003e8\u003c/strong\u003e(8):935-949.\u003c/li\u003e\n\u003cli\u003eCroome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML: \u003cstrong\u003ePancreaticoduodenectomy with major vascular resection: a comparison of laparoscopic versus open approaches\u003c/strong\u003e. \u003cem\u003eJ Gastrointest Surg \u003c/em\u003e2015, \u003cstrong\u003e19\u003c/strong\u003e(1):189-194.\u003c/li\u003e\n\u003cli\u003eKendrick ML, Sclabas GM: \u003cstrong\u003eMajor venous resection during total laparoscopic pancreaticoduodenectomy\u003c/strong\u003e. \u003cem\u003eHPB \u003c/em\u003e2011, \u003cstrong\u003e13\u003c/strong\u003e(7):454-458.\u003c/li\u003e\n\u003cli\u003eKendrick ML, van Hilst J, Boggi U, de Rooij T, Walsh RM, Zeh HJ, Hughes SJ, Nakamura Y, Vollmer CM, Kooby DA\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eMinimally invasive pancreatoduodenectomy\u003c/strong\u003e. \u003cem\u003eHPB : the official journal of the International Hepato Pancreato Biliary Association \u003c/em\u003e2017, \u003cstrong\u003e19\u003c/strong\u003e(3):215-224.\u003c/li\u003e\n\u003cli\u003eCallery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM, Jr.: \u003cstrong\u003eA prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy\u003c/strong\u003e. \u003cem\u003eJournal of the American College of Surgeons \u003c/em\u003e2013, \u003cstrong\u003e216\u003c/strong\u003e(1):1-14.\u003c/li\u003e\n\u003cli\u003ePanni RZ, Guerra J, Hawkins WG, Hall BL, Asbun HJ, Sanford DE: \u003cstrong\u003eNational Pancreatic Fistula Rates after Minimally Invasive Pancreaticoduodenectomy: A NSQIP Analysis\u003c/strong\u003e. \u003cem\u003eJournal of the American College of Surgeons \u003c/em\u003e2019, \u003cstrong\u003e21\u003c/strong\u003e(19):30151-30156.\u003c/li\u003e\n\u003cli\u003eAkizuki E, Kimura Y, Nobuoka T, Imamura M, Nagayama M, Sonoda T, Hirata K: \u003cstrong\u003eReconsideration of postoperative oral intake tolerance after pancreaticoduodenectomy: prospective consecutive analysis of delayed gastric emptying according to the ISGPS definition and the amount of dietary intake\u003c/strong\u003e. \u003cem\u003eAnnals of surgery \u003c/em\u003e2009, \u003cstrong\u003e249\u003c/strong\u003e(6):986-994.\u003c/li\u003e\n\u003cli\u003eMarsh Rde W, Talamonti MS, Katz MH, Herman JM: \u003cstrong\u003ePancreatic cancer and FOLFIRINOX: a new era and new questions\u003c/strong\u003e. \u003cem\u003eCancer Med \u003c/em\u003e2015, \u003cstrong\u003e4\u003c/strong\u003e(6):853-863.\u003c/li\u003e\n\u003cli\u003ePark YC, Kim SW, Jang JY, Ahn YJ, Park YH: \u003cstrong\u003eFactors influencing delayed gastric emptying after pylorus-preserving pancreatoduodenectomy\u003c/strong\u003e. \u003cem\u003eJ Am Coll Surg \u003c/em\u003e2003, \u003cstrong\u003e196\u003c/strong\u003e(6):859-865.\u003c/li\u003e\n\u003cli\u003eJung JP, Zenati MS, Dhir M, Zureikat AH, Zeh HJ, Simmons RL, Hogg ME: \u003cstrong\u003eUse of Video Review to Investigate Technical Factors That May Be Associated With Delayed Gastric Emptying After Pancreaticoduodenectomy\u003c/strong\u003e. \u003cem\u003eJAMA Surg \u003c/em\u003e2018, \u003cstrong\u003e153\u003c/strong\u003e(10):918-927.\u003c/li\u003e\n\u003cli\u003eFuks D, Cauchy F, Fteriche S, Nomi T, Schwarz L, Dokmak S, Scatton O, Fusco G, Belghiti J, Gayet B\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eLaparoscopy Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection: A Propensity Score Analysis\u003c/strong\u003e. \u003cem\u003eAnnals of surgery \u003c/em\u003e2016, \u003cstrong\u003e263\u003c/strong\u003e(2):353-361.\u003c/li\u003e\n\u003cli\u003eSulpice L, Farges O, Goutte N, Bendersky N, Dokmak S, Sauvanet A, Delpero JR: \u003cstrong\u003eLaparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study\u003c/strong\u003e. \u003cem\u003eAnn Surg \u003c/em\u003e2015, \u003cstrong\u003e262\u003c/strong\u003e(5):868-873.\u003c/li\u003e\n\u003cli\u003eStevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J: \u003cstrong\u003eEffect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial\u003c/strong\u003e. \u003cem\u003eJama \u003c/em\u003e2015, \u003cstrong\u003e314\u003c/strong\u003e(13):1356-1363.\u003c/li\u003e\n\u003cli\u003eRamirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eMinimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer\u003c/strong\u003e. \u003cem\u003eN Engl J Med \u003c/em\u003e2018, \u003cstrong\u003e379\u003c/strong\u003e(20):1895-1904.\u003c/li\u003e\n\u003cli\u003eYu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X\u003cem\u003e et al\u003c/em\u003e: \u003cstrong\u003eEffect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial\u003c/strong\u003e. \u003cem\u003eJama \u003c/em\u003e2019, \u003cstrong\u003e321\u003c/strong\u003e(20):1983-1992.\u003c/li\u003e\n\u003cli\u003eHoward TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, Madura JA, Wiebke EA, Lillemoe KD: \u003cstrong\u003eA margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer\u003c/strong\u003e. \u003cem\u003eJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract \u003c/em\u003e2006, \u003cstrong\u003e10\u003c/strong\u003e(10):1338-1345.\u003c/li\u003e\n\u003cli\u003eNussbaum DP, Adam MA, Youngwirth LM, Ganapathi AM, Roman SA, Tyler DS, Sosa JA, Blazer DG, 3rd: \u003cstrong\u003eMinimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma\u003c/strong\u003e. \u003cem\u003eAnn Surg Oncol \u003c/em\u003e2016, \u003cstrong\u003e23\u003c/strong\u003e(3):1026-1033.\u003c/li\u003e\n\u003cli\u003eKim HW, Lee JC, Lee J, Kim JW, Kim J, Hwang JH: \u003cstrong\u003eEarly versus delayed initiation of adjuvant treatment for pancreatic cancer\u003c/strong\u003e. \u003cem\u003ePLoS One \u003c/em\u003e2017, \u003cstrong\u003e12\u003c/strong\u003e(3).\u003c/li\u003e\n\u003cli\u003eMirkin KA, Greenleaf EK, Hollenbeak CS, Wong J: \u003cstrong\u003eTime to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer\u003c/strong\u003e. \u003cem\u003eCancer \u003c/em\u003e2016, \u003cstrong\u003e122\u003c/strong\u003e(19):2979-2987.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Laparoscopy, Pancreaticoduodenectomy, Adenocarcinoma, Morbidity, Survival","lastPublishedDoi":"10.21203/rs.3.rs-20225/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-20225/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eBackground \u003c/p\u003e\u003cp\u003ePancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Total laparoscopic pancreaticoduodenectomy (TLPD) have been used in the treatment of benign and low-grade diseases on the pancreatic head. It is necessary to expand the current knowledge on the feasibility and safety of TLPD for PDAC treatment. We aimed to assess the surgical and oncological outcomes of TLPD for patients with PDAC by comparing them with open pancreaticoduodenectomy (OPD). \u003c/p\u003e\u003cp\u003eMethods \u003c/p\u003e\u003cp\u003eData regarding patients who underwent pancreaticoduodenectomy for PDAC treatment from January 2013 to January 2019 in our hospital were obtained. Baseline characteristics, intraoperative effects, postoperative recoveries, and survival outcomes were compared. To overcome selection bias, we performed a 1:1 match using propensity score matching (PSM) between TLPD and OPD. We also conducted a systematic review and meta-analysis. \u003c/p\u003e\u003cp\u003eResults \u003c/p\u003e\u003cp\u003eThe original cohort included 276 patients (TLPD; 98 patients, OPD; 178 patients). After PSM, there were 89 patients in each group and the patient demographics were well matched. Of the 98 patients who underwent TLPD, 8 (8.2%) required conversions to laparotomies. Compared to OPD, TLPD could be performed with longer operative times, had less blood loss, and had lower overall morbidities. Regarding oncological and survival outcomes, there were no significant differences in tumor size, R0 resection rates and tumor stages between groups. However, TLPD had an advantage over OPD in terms of retrieved lymph nodes (21.9 ± 6.6 vs. 18.9 ± 5.4, p \u0026lt; 0.01). There were no statistically significant differences between the groups in recurrence patterns, and the 3-year recurrence-free and overall survival rates were comparable between the two groups. Meta-analysis further confirmed that the TLPD were associated with longer operative times, less blood loss, shorter hospitalizations, lower morbidities, and a greater number of retrieved lymph nodes. \u003c/p\u003e\u003cp\u003eConclusions \u003c/p\u003e\u003cp\u003eTLPD are feasible and oncologically safe procedures for PDAC treatments. Postoperative outcomes and long-term survival after TLPD are superior, or not inferior, to OPD, and could be a promising alternative to open surgery for PDAC treatments. Our findings should be further evaluated by multicenter or randomized controlled trials.\u003c/p\u003e","manuscriptTitle":"Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis with meta-analysis","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2020-04-06 17:21:49","doi":"10.21203/rs.3.rs-20225/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"8bc9beb4-757f-4b6b-880b-5489ac67e2de","owner":[],"postedDate":"April 6th, 2020","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":79592,"name":"Cancer Biology"},{"id":79593,"name":"Oncology"}],"tags":[],"updatedAt":"2020-05-29T02:57:52+00:00","versionOfRecord":[],"versionCreatedAt":"2020-04-06 17:21:49","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-20225","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-20225","identity":"rs-20225","version":["v1"]},"buildId":"7rjqhiLT3MXkJMwkYKINL","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.